{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:26:49Z","timestamp":1793654809697,"version":"4.5.1"},"reference-count":318,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYJC21067"],"award-info":[{"award-number":["ZYJC21067"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302632"],"award-info":[{"award-number":["82302632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Clinical Research Center for Gastrointestinal Cancer In Hunan Province","award":["2021SK4016"],"award-info":[{"award-number":["2021SK4016"]}]},{"name":"the Clinical Research Center for Gastrointestinal Cancer In Hunan Province","award":["2021SK4016"],"award-info":[{"award-number":["2021SK4016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute kidney injury (AKI) is a prevalent clinical condition that is associated with unacceptably high morbidity and mortality, as well as the development of chronic kidney disease (CKD). The pathogenesis of AKI is highly complex and heterogeneous, primarily attributed to metabolic disturbances arising from the disease itself and the administration of medications related to treatment. In recent years, AKI in cancer patients is highly concerned. The emergence of AKI caused injuries and dysfunction of remote organs but also enhanced the health-care costs. It's essential for early recognition of AKI by biomarker or prediction models and further, take a timely intervention. This review aims to provide the pathophysiology of AKI covering the intricate mechanisms underpinning AKI in the dynamic context of the clinical setting, the tailored role of inflammation and ischemia, and the cellular and molecular crosstalk pathways involved. These events closely related to patients at high risk of AKI and underscore the characteristics that may make these patients more susceptible to injury. Furthermore, the diagnosis of AKI relies on clinical criteria, biomarkers, and imaging, but it should be distinguished from CKD. Finally, the review offers the therapeutic intervention in clinical practice and preclinical or clinical trials, focusing on the improvement of conventional therapy and advanced novel treatment strategies. Simultaneously, the challenge and future direction on early identifying renal impairment and performing renoprotection are also discussed, further supporting the novel discipline including onco-nephrology. The development of effective interventions that reduce nephrotoxicity is highly contingent upon a thorough understanding of the molecular pathophysiology of AKI.<\/jats:p>","DOI":"10.1186\/s43556-025-00293-4","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T06:21:30Z","timestamp":1757053290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Acute kidney injury: pathogenesis and therapeutic interventions"],"prefix":"10.1186","volume":"6","author":[{"given":"Xiaoqin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"issue":"10474","key":"293_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(24)02385-7","volume":"405","author":"M Ostermann","year":"2025","unstructured":"Ostermann M, Lumlertgul N, Jeong R, See E, Joannidis M, James M. Acute kidney injury. Lancet. 2025;405(10474):241\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(24)02385-7.","journal-title":"Lancet"},{"issue":"5","key":"293_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S2468-1253(25)00006-8","volume":"10","author":"KR Patidar","year":"2025","unstructured":"Patidar KR, Ma AT, Juanola A, Barone A, Incicco S, Kulkarni AV, et al. Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2025;10(5):418\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(25)00006-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"293_CR3","doi-asserted-by":"publisher","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative w. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204\u201312. https:\/\/doi.org\/10.1186\/cc2872","DOI":"10.1186\/cc2872"},{"issue":"2","key":"293_CR4","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. https:\/\/doi.org\/10.1186\/cc5713.","journal-title":"Crit Care"},{"key":"293_CR5","doi-asserted-by":"publisher","unstructured":"Section 2: AKI Definition. Kidney Int Suppl (2011). 2012;2(1):19\u201336. https:\/\/doi.org\/10.1038\/kisup.2011.32","DOI":"10.1038\/kisup.2011.32"},{"key":"293_CR6","doi-asserted-by":"publisher","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, Viera A. Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies. Actas Dermosifiliogr (Engl Ed). 2021;112(1):90\u20132. https:\/\/doi.org\/10.1016\/j.ad.2019.05.009","DOI":"10.1016\/j.ad.2019.05.009"},{"issue":"3","key":"293_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70646","volume":"14","author":"PV Munch","year":"2025","unstructured":"Munch PV, Norgaard M, Jensen SK, Birn H, Schmidt H, Christiansen CF.\u00a0Risk of and mortality after acute kidney injury following cancer treatment: a cohort study. Cancer Med. 2025;14(3): e70646. https:\/\/doi.org\/10.1002\/cam4.70646.","journal-title":"Cancer Med"},{"issue":"11","key":"293_CR8","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1002\/ijc.31993","volume":"144","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Nie S, Li L, Li Y, Liu D, Xiong M, et al. Epidemiology and outcomes of acute kidney injury in hospitalized cancer patients in China. Int J Cancer. 2019;144(11):2644\u201350. https:\/\/doi.org\/10.1002\/ijc.31993.","journal-title":"Int J Cancer"},{"issue":"1","key":"293_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1186\/s12885-023-11561-3","volume":"23","author":"W Can","year":"2023","unstructured":"Can W, Rong L, Lixia L. Incidence and risk factors of acute kidney injury in patients with malignant tumors: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):1123. https:\/\/doi.org\/10.1186\/s12885-023-11561-3.","journal-title":"BMC Cancer"},{"issue":"5","key":"293_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232370","volume":"15","author":"N Seylanova","year":"2020","unstructured":"Seylanova N, Crichton S, Zhang J, Fisher R, Ostermann M. Acute kidney injury in critically ill cancer patients is associated with mortality: A retrospective analysis. PLoS ONE. 2020;15(5): e0232370. https:\/\/doi.org\/10.1371\/journal.pone.0232370.","journal-title":"PLoS ONE"},{"key":"293_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijsu.2017.01.043","volume":"39","author":"W Wang","year":"2017","unstructured":"Wang W, Wang T, Feng X, Sun L. Incidence and risk factors of acute kidney injury after esophageal cancer surgery: A nested case-control study. Int J Surg. 2017;39:11\u20135. https:\/\/doi.org\/10.1016\/j.ijsu.2017.01.043.","journal-title":"Int J Surg"},{"issue":"5","key":"293_CR12","doi-asserted-by":"publisher","first-page":"e683","DOI":"10.1097\/SLA.0000000000004146","volume":"275","author":"CF Murphy","year":"2022","unstructured":"Murphy CF, Dunne T, Elliott JA, Kamarajah SK, Leighton J, Evans RPT, et al. Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes. Ann Surg. 2022;275(5):e683\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000004146.","journal-title":"Ann Surg"},{"issue":"7","key":"293_CR13","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/jcm10071438","volume":"10","author":"JH Sim","year":"2021","unstructured":"Sim JH, Kang SJ, Bang JY, Song JG. Comparison of the Effects of Laparoscopic and Open Surgery on Postoperative Acute Kidney Injury in Patients with Colorectal Cancer: Propensity Score Analysis. J Clin Med. 2021;10(7):1438. https:\/\/doi.org\/10.3390\/jcm10071438.","journal-title":"J Clin Med."},{"issue":"2","key":"293_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1245\/s10434-015-4886-4","volume":"23","author":"T Kwon","year":"2016","unstructured":"Kwon T, Jeong IG, Lee C, You D, Hong B, Hong JH, et al. Acute Kidney Injury After Radical Cystectomy for Bladder Cancer is Associated with Chronic Kidney Disease and Mortality. Ann Surg Oncol. 2016;23(2):686\u201393. https:\/\/doi.org\/10.1245\/s10434-015-4886-4.","journal-title":"Ann Surg Oncol"},{"key":"293_CR15","doi-asserted-by":"publisher","unstructured":"Schmid M, Krishna N, Ravi P, Meyer CP, Becker A, Dalela D, et al. Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma. Urol Oncol. 2016;34(7):293.e1-e10. https:\/\/doi.org\/10.1016\/j.urolonc.2016.02.018.","DOI":"10.1016\/j.urolonc.2016.02.018"},{"key":"293_CR16","doi-asserted-by":"publisher","first-page":"1094410","DOI":"10.3389\/fonc.2023.1094410","volume":"13","author":"Y Bai","year":"2023","unstructured":"Bai Y, Du Y, Ye P, Luo Y. Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer. Front Oncol. 2023;13:1094410. https:\/\/doi.org\/10.3389\/fonc.2023.1094410.","journal-title":"Front Oncol"},{"key":"293_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.627895","volume":"12","author":"Z Mou","year":"2022","unstructured":"Mou Z, Guan T, Chen L. Acute Kidney Injury in Adult Patients With Hepatocellular Carcinoma After TACE or Hepatectomy Treatment. Front Oncol. 2022;12: 627895. https:\/\/doi.org\/10.3389\/fonc.2022.627895.","journal-title":"Front Oncol"},{"issue":"11","key":"293_CR18","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00345-022-04156-3","volume":"40","author":"A Tafuri","year":"2022","unstructured":"Tafuri A, Marchioni M, Cerrato C, Mari A, Tellini R, Odorizzi K, et al. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium). World J Urol. 2022;40(11):2771\u20139. https:\/\/doi.org\/10.1007\/s00345-022-04156-3.","journal-title":"World J Urol"},{"key":"293_CR19","doi-asserted-by":"publisher","first-page":"1173578","DOI":"10.3389\/fonc.2023.1173578","volume":"13","author":"F Trevisani","year":"2023","unstructured":"Trevisani F, Di Marco F, Quattrini G, Lepori N, Floris M, Valsecchi D, et al. Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer. Front Oncol. 2023;13:1173578. https:\/\/doi.org\/10.3389\/fonc.2023.1173578.","journal-title":"Front Oncol"},{"issue":"2","key":"293_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00520-020-05566-y","volume":"29","author":"T Patimarattananan","year":"2021","unstructured":"Patimarattananan T, Nongnuch A, Pattaranutaporn P, Unwanatham N, Jiarpinitnun C, Ngamphaiboon N. Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin. Support Care Cancer. 2021;29(2):877\u201387. https:\/\/doi.org\/10.1007\/s00520-020-05566-y.","journal-title":"Support Care Cancer"},{"issue":"5","key":"293_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000504354","volume":"143","author":"M Sakaguchi","year":"2020","unstructured":"Sakaguchi M, Nakayama K, Yamaguchi H, Mii A, Shimizu A, Inai K, et al. Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies. Acta Haematol. 2020;143(5):452\u201364. https:\/\/doi.org\/10.1159\/000504354.","journal-title":"Acta Haematol"},{"key":"293_CR22","doi-asserted-by":"publisher","first-page":"1173952","DOI":"10.3389\/fimmu.2023.1173952","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu C, Wei W, Yang L, Li J, Yi C, Pu Y, et al. Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Immunol. 2023;14:1173952. https:\/\/doi.org\/10.3389\/fimmu.2023.1173952.","journal-title":"Front Immunol"},{"issue":"7","key":"293_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10157-023-02344-y","volume":"27","author":"H Yan","year":"2023","unstructured":"Yan H, Tang M, Zhu W, Yang Y. Immune checkpoint inhibitor-associated acute kidney injury in patients with cancer: a systematic review and meta-analysis of risk factors. Clin Exp Nephrol. 2023;27(7):603\u201312. https:\/\/doi.org\/10.1007\/s10157-023-02344-y.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"293_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41391-021-00415-3","volume":"26","author":"MV Sherer","year":"2023","unstructured":"Sherer MV, Deka R, Salans MA, Nelson TJ, Sheridan P, Rose BS. Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy. Prostate Cancer Prostatic Dis. 2023;26(2):276\u201381. https:\/\/doi.org\/10.1038\/s41391-021-00415-3.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"293_CR25","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3171\/2016.11.JNS162237","volume":"128","author":"K Kim","year":"2018","unstructured":"Kim K, Bang JY, Kim SO, Kim S, Kim JU, Song JG. Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study. J Neurosurg. 2018;128(4):1115\u201322. https:\/\/doi.org\/10.3171\/2016.11.JNS162237.","journal-title":"J Neurosurg"},{"issue":"21","key":"293_CR26","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.3390\/jcm12216894","volume":"12","author":"J Udzik","year":"2023","unstructured":"Udzik J, Pacholewicz J, Biskupski A, Walerowicz P, Januszkiewicz K, Kwiatkowska E. Alterations to Kidney Physiology during Cardiopulmonary Bypass-A Narrative Review of the Literature and Practical Remarks. J Clin Med. 2023;12(21):6894. https:\/\/doi.org\/10.3390\/jcm12216894.","journal-title":"J Clin Med."},{"issue":"17","key":"293_CR27","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jama.2024.20630","volume":"332","author":"X Perez-Fernandez","year":"2024","unstructured":"Perez-Fernandez X, Ulsamer A, Camara-Rosell M, Sbraga F, Boza-Hernandez E, Moret-Ruiz E, et al. Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery: The SIRAKI02 Randomized Clinical Trial. JAMA. 2024;332(17):1446\u201354. https:\/\/doi.org\/10.1001\/jama.2024.20630.","journal-title":"JAMA"},{"key":"293_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ahj.2025.01.002","volume":"282","author":"F Cossette","year":"2025","unstructured":"Cossette F, Trifan A, Prevost-Marcotte G, Doolub G, So DF, Beaubien-Souligny W, et al. Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis. Am Heart J. 2025;282:93\u2013102. https:\/\/doi.org\/10.1016\/j.ahj.2025.01.002.","journal-title":"Am Heart J"},{"issue":"10","key":"293_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","volume":"14","author":"EAJ Hoste","year":"2018","unstructured":"Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607\u201325. https:\/\/doi.org\/10.1038\/s41581-018-0052-0.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"293_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3322\/caac.21636","volume":"71","author":"MH Rosner","year":"2021","unstructured":"Rosner MH, Jhaveri KD, McMahon BA, Perazella MA. Onconephrology: The intersections between the kidney and cancer. CA Cancer J Clin. 2021;71(1):47\u201377. https:\/\/doi.org\/10.3322\/caac.21636.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"293_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10157-021-02131-7","volume":"26","author":"S Liu","year":"2022","unstructured":"Liu S, Zhao J, Wang F. Acute kidney injury in cancer patients. Clin Exp Nephrol. 2022;26(2):103\u201312. https:\/\/doi.org\/10.1007\/s10157-021-02131-7.","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"293_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/jnci\/djy167","volume":"111","author":"A Kitchlu","year":"2019","unstructured":"Kitchlu A, McArthur E, Amir E, Booth CM, Sutradhar R, Majeed H, et al. Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study. J Natl Cancer Inst. 2019;111(7):727\u201336. https:\/\/doi.org\/10.1093\/jnci\/djy167.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"293_CR33","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/cam4.2140","volume":"8","author":"E Kang","year":"2019","unstructured":"Kang E, Park M, Park PG, Park N, Jung Y, Kang U, et al. Acute kidney injury predicts all-cause mortality in patients with cancer. Cancer Med. 2019;8(6):2740\u201350. https:\/\/doi.org\/10.1002\/cam4.2140.","journal-title":"Cancer Med"},{"issue":"1","key":"293_CR34","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1038\/s41598-019-39735-9","volume":"9","author":"J Jin","year":"2019","unstructured":"Jin J, Wang Y, Shen Q, Gong J, Zhao L, He Q. Acute kidney injury in cancer patients: A nationwide survey in China. Sci Rep. 2019;9(1):3540. https:\/\/doi.org\/10.1038\/s41598-019-39735-9.","journal-title":"Sci Rep"},{"key":"293_CR35","doi-asserted-by":"publisher","first-page":"2972275","DOI":"10.1155\/2022\/2972275","volume":"2022","author":"Z Nazzal","year":"2022","unstructured":"Nazzal Z, Abdeljaleel F, Ashayer A, Salameh H, Hamdan Z. The Rate and Risk Factors of Acute Kidney Injury among Cancer Patients\u2019 Admissions in Palestine: A Single-Center Study. Int J Nephrol. 2022;2022:2972275. https:\/\/doi.org\/10.1155\/2022\/2972275.","journal-title":"Int J Nephrol"},{"issue":"4","key":"293_CR36","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4143\/crt.2020.1010","volume":"53","author":"S Cho","year":"2021","unstructured":"Cho S, Kang E, Kim JE, Kang U, Kang HG, Park M, et al. Clinical Significance of Acute Kidney Injury in Lung Cancer Patients. Cancer Res Treat. 2021;53(4):1015\u201323. https:\/\/doi.org\/10.4143\/crt.2020.1010.","journal-title":"Cancer Res Treat"},{"issue":"12","key":"293_CR37","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.7150\/ijms.100367","volume":"21","author":"Z Wang","year":"2024","unstructured":"Wang Z, Hu D, Xu H, Zeng R, Yao Y. Increased Lymphatic Vessels: A Risk Factor for Severe Renal Function Loss in Obstructive Nephropathy Patients. Int J Med Sci. 2024;21(12):2305\u201314. https:\/\/doi.org\/10.7150\/ijms.100367.","journal-title":"Int J Med Sci"},{"issue":"1","key":"293_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13054-019-2710-4","volume":"24","author":"T Folkestad","year":"2020","unstructured":"Folkestad T, Brurberg KG, Nordhuus KM, Tveiten CK, Guttormsen AB, Os I, et al. Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysis. Crit Care. 2020;24(1):2. https:\/\/doi.org\/10.1186\/s13054-019-2710-4.","journal-title":"Crit Care"},{"issue":"1","key":"293_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s13054-024-05202-9","volume":"28","author":"IB Stanaway","year":"2024","unstructured":"Stanaway IB, Morrell ED, Mabrey FL, Sathe NA, Bailey Z, Speckmaier S, et al. Urinary proteomics identifies distinct immunological profiles of sepsis associated AKI sub-phenotypes. Crit Care. 2024;28(1):419. https:\/\/doi.org\/10.1186\/s13054-024-05202-9.","journal-title":"Crit Care"},{"issue":"24","key":"293_CR40","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1056\/NEJMoa1801601","volume":"378","author":"PS Myles","year":"2018","unstructured":"Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, et al. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N Engl J Med. 2018;378(24):2263\u201374. https:\/\/doi.org\/10.1056\/NEJMoa1801601.","journal-title":"N Engl J Med"},{"issue":"1","key":"293_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41408-023-00806-w","volume":"13","author":"N Leung","year":"2023","unstructured":"Leung N, Rajkumar SV. Multiple myeloma with acute light chain cast nephropathy. Blood Cancer J. 2023;13(1):46. https:\/\/doi.org\/10.1038\/s41408-023-00806-w.","journal-title":"Blood Cancer J"},{"issue":"5","key":"293_CR42","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00467-022-05775-z","volume":"38","author":"BR Stotter","year":"2023","unstructured":"Stotter BR, Cody E, Gu H, Daga A, Greenbaum LA, Duong MD, et al. Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance. Pediatr Nephrol. 2023;38(5):1653\u201365. https:\/\/doi.org\/10.1007\/s00467-022-05775-z.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"293_CR43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/bmt.2015.2","volume":"50","author":"SR Hingorani","year":"2015","unstructured":"Hingorani SR, Seidel K, Pao E, Lawler R, McDonald GB. Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation. Bone Marrow Transplant. 2015;50(5):715\u201320. https:\/\/doi.org\/10.1038\/bmt.2015.2.","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"293_CR44","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.2169\/internalmedicine.55.6724","volume":"55","author":"T Sugase","year":"2016","unstructured":"Sugase T, Akimoto T, Kubo T, Imai T, Otani-Takei N, Miki T, et al. Acute Kidney Injury Associated with Renal Cell Carcinoma Complicated by Renal Vein and Inferior Vena Cava Involvement. Intern Med. 2016;55(17):2447\u201352. https:\/\/doi.org\/10.2169\/internalmedicine.55.6724.","journal-title":"Intern Med"},{"issue":"5","key":"293_CR45","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bbmt.2019.11.027","volume":"26","author":"Y Wang","year":"2020","unstructured":"Wang Y, Qi K, Cheng H, Cao J, Shi M, Qiao J, et al. Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies. Biol Blood Marrow Transplant. 2020;26(5):865\u201375. https:\/\/doi.org\/10.1016\/j.bbmt.2019.11.027.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"293_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.krcp.2015.06.001","volume":"34","author":"H Ryu","year":"2015","unstructured":"Ryu H, Kang E, Park S, Park S, Lee K, Joo KW, et al. A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney. Kidney Res Clin Pract. 2015;34(4):237\u201340. https:\/\/doi.org\/10.1016\/j.krcp.2015.06.001.","journal-title":"Kidney Res Clin Pract"},{"issue":"5","key":"293_CR47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/ckj\/sfv059","volume":"8","author":"A Lodhi","year":"2015","unstructured":"Lodhi A, Kumar A, Saqlain MU, Suneja M. Thrombotic microangiopathy associated with proteasome inhibitors. Clin Kidney J. 2015;8(5):632\u20136. https:\/\/doi.org\/10.1093\/ckj\/sfv059.","journal-title":"Clin Kidney J"},{"key":"293_CR48","doi-asserted-by":"publisher","unstructured":"Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020;16(12):747\u201364. https:\/\/doi.org\/10.1038\/s41581-020-00356-5.","DOI":"10.1038\/s41581-020-00356-5"},{"issue":"4","key":"293_CR49","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/jamainternmed.2023.8225","volume":"184","author":"AM Aklilu","year":"2024","unstructured":"Aklilu AM, Kumar S, Nugent J, Yamamoto Y, Coronel-Moreno C, Kadhim B, et al. COVID-19-Associated Acute Kidney Injury and Longitudinal Kidney Outcomes. JAMA Intern Med. 2024;184(4):414\u201323. https:\/\/doi.org\/10.1001\/jamainternmed.2023.8225.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"293_CR50","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1001\/jamainternmed.2021.8538","volume":"182","author":"AM Hung","year":"2022","unstructured":"Hung AM, Shah SC, Bick AG, Yu Z, Chen HC, Hunt CM, et al. APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program. JAMA Intern Med. 2022;182(4):386\u201395. https:\/\/doi.org\/10.1001\/jamainternmed.2021.8538.","journal-title":"JAMA Intern Med"},{"key":"293_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155974","volume":"157","author":"T Medeiros","year":"2022","unstructured":"Medeiros T, Guimaraes GMC, Carvalho FR, Alves LS, Faustino R, Campi-Azevedo AC, et al. Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators. Cytokine. 2022;157: 155974. https:\/\/doi.org\/10.1016\/j.cyto.2022.155974.","journal-title":"Cytokine"},{"issue":"1","key":"293_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41581-022-00652-2","volume":"19","author":"Z Al-Aly","year":"2023","unstructured":"Al-Aly Z, Agarwal A, Alwan N, Luyckx VA. Long COVID: long-term health outcomes and implications for policy and research. Nat Rev Nephrol. 2023;19(1):1\u20132. https:\/\/doi.org\/10.1038\/s41581-022-00652-2.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"293_CR53","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1002\/cphy.c220026","volume":"13","author":"D Moronge","year":"2023","unstructured":"Moronge D, Sullivan JC, Faulkner JL. Physiology of Pregnancy-Related Acute Kidney Injury. Compr Physiol. 2023;13(3):4869\u201378. https:\/\/doi.org\/10.1002\/cphy.c220026.","journal-title":"Compr Physiol"},{"key":"293_CR54","doi-asserted-by":"publisher","unstructured":"Meena J, Kumar J, Kocharlakota JP, Gupta H, Mittal P, Kumar A, et al. Acute Kidney Injury in Neonates: A Meta-Analysis. Pediatrics. 2024;154(1):e2023065182. https:\/\/doi.org\/10.1542\/peds.2023-065182.","DOI":"10.1542\/peds.2023-065182"},{"issue":"2","key":"293_CR55","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.55307","volume":"7","author":"AD Rutledge","year":"2024","unstructured":"Rutledge AD, Griffin RL, Vincent K, Askenazi DJ, Segar JL, Kupferman JC, et al. Incidence, Risk Factors, and Outcomes Associated With Recurrent Neonatal Acute Kidney Injury in the AWAKEN Study. JAMA Netw Open. 2024;7(2): e2355307. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.55307.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"293_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.0000000000000018","volume":"34","author":"AA Ejaz","year":"2023","unstructured":"Ejaz AA, Mohandas R, Beaver TM, Johnson RJ. A Crystal-Independent Role for Uric Acid in AKI Associated with Tumor Lysis Syndrome. J Am Soc Nephrol. 2023;34(1):175. https:\/\/doi.org\/10.1681\/ASN.0000000000000018.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"293_CR57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/17511437221106441","volume":"24","author":"R Chapman","year":"2023","unstructured":"Chapman R, Shah S, D\u2019Angelo A. Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical care. J Intensive Care Soc. 2023;24(1):112\u20136. https:\/\/doi.org\/10.1177\/17511437221106441.","journal-title":"J Intensive Care Soc"},{"issue":"5","key":"293_CR58","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/biomedicines10051012","volume":"10","author":"G Lupusoru","year":"2022","unstructured":"Lupusoru G, Ailincai I, Fratila G, Ungureanu O, Andronesi A, Lupusoru M, et al. Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology. Biomedicines. 2022;10(5):1012. https:\/\/doi.org\/10.3390\/biomedicines10051012.","journal-title":"Biomedicines."},{"issue":"6","key":"293_CR59","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1681\/ASN.2021070997","volume":"33","author":"M Arnaud","year":"2022","unstructured":"Arnaud M, Loiselle M, Vaganay C, Pons S, Letavernier E, Demonchy J, et al. Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms. J Am Soc Nephrol. 2022;33(6):1154\u201371. https:\/\/doi.org\/10.1681\/ASN.2021070997.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"293_CR60","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34557","volume":"15","author":"S Koura","year":"2023","unstructured":"Koura S, Parekh V, Parikh AD, Kaur K, Dunn BK. Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer. Cureus. 2023;15(2): e34557. https:\/\/doi.org\/10.7759\/cureus.34557.","journal-title":"Cureus"},{"issue":"1","key":"293_CR61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13256-022-03263-4","volume":"16","author":"M Shafie","year":"2022","unstructured":"Shafie M, Teymouri A, Parsa S, Sadeghian A, Zarei JN. Spontaneous tumor lysis syndrome in adrenal adenocarcinoma: a case report and review of the literature. J Med Case Rep. 2022;16(1):52. https:\/\/doi.org\/10.1186\/s13256-022-03263-4.","journal-title":"J Med Case Rep"},{"issue":"12","key":"293_CR62","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12169","volume":"12","author":"JA Kalter","year":"2020","unstructured":"Kalter JA, Allen J, Yang Y, Willing T, Evans E. Spontaneous Tumor Lysis Syndrome in an Adenocarcinoma of Unknown Origin. Cureus. 2020;12(12): e12169. https:\/\/doi.org\/10.7759\/cureus.12169.","journal-title":"Cureus"},{"issue":"5","key":"293_CR63","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana S, Manrique-Caballero CL, Gomez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083\u201399. https:\/\/doi.org\/10.1016\/j.kint.2019.05.026.","journal-title":"Kidney Int"},{"key":"293_CR64","doi-asserted-by":"publisher","first-page":"1015735","DOI":"10.3389\/fmed.2022.1015735","volume":"9","author":"Y Yang","year":"2022","unstructured":"Yang Y, Dong J, Chen X, Chen R, Wang H. Incidence, risk factors and clinical outcomes of septic acute renal injury in cancer patients with sepsis admitted to the ICU: A retrospective study. Front Med (Lausanne). 2022;9:1015735. https:\/\/doi.org\/10.3389\/fmed.2022.1015735.","journal-title":"Front Med (Lausanne)"},{"issue":"10212","key":"293_CR65","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","volume":"394","author":"C Ronco","year":"2019","unstructured":"Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(19)32563-2.","journal-title":"Lancet"},{"issue":"5","key":"293_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2023.151466","volume":"43","author":"A Batte","year":"2023","unstructured":"Batte A, Shahrin L, Claure-Del Granado R, Luyckx VA, Conroy AL. Infections and Acute Kidney Injury: A Global Perspective. Semin Nephrol. 2023;43(5): 151466. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151466.","journal-title":"Semin Nephrol"},{"issue":"1","key":"293_CR67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13054-020-03424-1","volume":"25","author":"EC van der Slikke","year":"2021","unstructured":"van der Slikke EC, Star BS, van Meurs M, Henning RH, Moser J, Bouma HR. Sepsis is associated with mitochondrial DNA damage and a reduced mitochondrial mass in the kidney of patients with sepsis-AKI. Crit Care. 2021;25(1):36. https:\/\/doi.org\/10.1186\/s13054-020-03424-1.","journal-title":"Crit Care"},{"key":"293_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115183","volume":"165","author":"A Balkrishna","year":"2023","unstructured":"Balkrishna A, Sinha S, Kumar A, Arya V, Gautam AK, Valis M, et al. Sepsis-mediated renal dysfunction: Pathophysiology, biomarkers and role of phytoconstituents in its management. Biomed Pharmacother. 2023;165: 115183. https:\/\/doi.org\/10.1016\/j.biopha.2023.115183.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"293_CR69","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41419-024-06696-5","volume":"15","author":"S Han","year":"2024","unstructured":"Han S, Jin R, Huo L, Teng Y, Zhao L, Zhang K, et al. HIF-1alpha participates in the regulation of S100A16-HRD1-GSK3beta\/CK1alpha pathway in renal hypoxia injury. Cell Death Dis. 2024;15(5):316. https:\/\/doi.org\/10.1038\/s41419-024-06696-5.","journal-title":"Cell Death Dis"},{"issue":"8","key":"293_CR70","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2215\/CJN.11290821","volume":"17","author":"MA Perazella","year":"2022","unstructured":"Perazella MA, Rosner MH. Drug-Induced Acute Kidney Injury. Clin J Am Soc Nephrol. 2022;17(8):1220\u201333. https:\/\/doi.org\/10.2215\/CJN.11290821.","journal-title":"Clin J Am Soc Nephrol"},{"key":"293_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115925","volume":"169","author":"M Guerrero-Hue","year":"2023","unstructured":"Guerrero-Hue M, Vallejo-Mudarra M, Garcia-Caballero C, Cordoba-David GM, Palomino-Antolin A, Herencia C, et al. Tweak\/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury. Biomed Pharmacother. 2023;169: 115925. https:\/\/doi.org\/10.1016\/j.biopha.2023.115925.","journal-title":"Biomed Pharmacother"},{"key":"293_CR72","doi-asserted-by":"publisher","unstructured":"Nadim MK, Kellum JA, Forni L, Francoz C, Asrani SK, Ostermann M, et al. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol. 2024;81(1):163\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2024.03.031.","DOI":"10.1016\/j.jhep.2024.03.031"},{"issue":"9","key":"293_CR73","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00535-024-02126-7","volume":"59","author":"T Miwa","year":"2024","unstructured":"Miwa T, Utakata Y, Hanai T, Aiba M, Unome S, Imai K, et al. Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance. J Gastroenterol. 2024;59(9):849\u201357. https:\/\/doi.org\/10.1007\/s00535-024-02126-7.","journal-title":"J Gastroenterol"},{"issue":"1","key":"293_CR74","doi-asserted-by":"publisher","first-page":"2349113","DOI":"10.1080\/0886022X.2024.2349113","volume":"46","author":"H Lin","year":"2024","unstructured":"Lin H, Guo X, Wang M, Su X, Qiao X. Risk factors and early prediction of cardiorenal syndrome type 3 among acute kidney injury patients: a cohort study. Ren Fail. 2024;46(1):2349113. https:\/\/doi.org\/10.1080\/0886022X.2024.2349113.","journal-title":"Ren Fail"},{"issue":"6","key":"293_CR75","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41581-021-00405-7","volume":"17","author":"F Bridoux","year":"2021","unstructured":"Bridoux F, Cockwell P, Glezerman I, Gutgarts V, Hogan JJ, Jhaveri KD, et al. Kidney injury and disease in patients with haematological malignancies. Nat Rev Nephrol. 2021;17(6):386\u2013401. https:\/\/doi.org\/10.1038\/s41581-021-00405-7.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"293_CR76","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1258\/ar.2011.110523","volume":"53","author":"AG Bach","year":"2012","unstructured":"Bach AG, Behrmann C, Holzhausen HJ, Katzer M, Arnold D, Spielmann RP, et al. Prevalence and patterns of renal involvement in imaging of malignant lymphoproliferative diseases. Acta Radiol. 2012;53(3):343\u20138. https:\/\/doi.org\/10.1258\/ar.2011.110523.","journal-title":"Acta Radiol"},{"issue":"2","key":"293_CR77","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s13730-022-00736-9","volume":"12","author":"Y Ohara","year":"2023","unstructured":"Ohara Y, Kobayashi N, Toda T, Matsui N. Renal infiltration of peripheral T-cell lymphoma, not otherwise specified, mimicking drug-induced acute interstitial nephritis. CEN Case Rep. 2023;12(2):146\u201351. https:\/\/doi.org\/10.1007\/s13730-022-00736-9.","journal-title":"CEN Case Rep"},{"issue":"4","key":"293_CR78","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1182\/blood-2010-08-302505","volume":"117","author":"WZ Ying","year":"2011","unstructured":"Ying WZ, Wang PX, Aaron KJ, Basnayake K, Sanders PW. Immunoglobulin light chains activate nuclear factor-kappaB in renal epithelial cells through a Src-dependent mechanism. Blood. 2011;117(4):1301\u20137. https:\/\/doi.org\/10.1182\/blood-2010-08-302505.","journal-title":"Blood"},{"issue":"1","key":"293_CR79","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D\u2019Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45\u201359. https:\/\/doi.org\/10.1038\/s41581-018-0077-4.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"293_CR80","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1172\/JCI125517","volume":"129","author":"WZ Ying","year":"2019","unstructured":"Ying WZ, Li X, Rangarajan S, Feng W, Curtis LM, Sanders PW. Immunoglobulin light chains generate proinflammatory and profibrotic kidney injury. J Clin Invest. 2019;129(7):2792\u2013806. https:\/\/doi.org\/10.1172\/JCI125517.","journal-title":"J Clin Invest"},{"issue":"3","key":"293_CR81","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/08860220600580423","volume":"28","author":"YK Wen","year":"2006","unstructured":"Wen YK, Chen ML. Acute renal failure secondary to small cell lung cancer with tumor infiltration of the kidneys. Ren Fail. 2006;28(3):261\u20134. https:\/\/doi.org\/10.1080\/08860220600580423.","journal-title":"Ren Fail"},{"issue":"2","key":"293_CR82","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s13730-020-00541-2","volume":"10","author":"A Miyamoto","year":"2021","unstructured":"Miyamoto A, Kawakami T, Kakinuma M, Sato R, Fukuoka K, Karube M, et al. Extensive bilateral renal metastases of non-small cell lung carcinoma caused acute kidney injury resulting in end-stage renal disease. CEN Case Rep. 2021;10(2):194\u20138. https:\/\/doi.org\/10.1007\/s13730-020-00541-2.","journal-title":"CEN Case Rep"},{"issue":"4","key":"293_CR83","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/ckj\/sfy099","volume":"12","author":"A Sannier","year":"2019","unstructured":"Sannier A, Dupuis E, Berger AK, Bischofs C, Massy ZA, Seidowsky A. Acute kidney injury associated with lymphangitic carcinomatosis. Clin Kidney J. 2019;12(4):527\u20139. https:\/\/doi.org\/10.1093\/ckj\/sfy099.","journal-title":"Clin Kidney J"},{"issue":"7","key":"293_CR84","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1158\/2159-8290.CD-20-1098","volume":"11","author":"JR Pitarresi","year":"2021","unstructured":"Pitarresi JR, Norgard RJ, Chiarella AM, Suzuki K, Bakir B, Sahu V, et al. PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability. Cancer Discov. 2021;11(7):1774\u201391. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1098.","journal-title":"Cancer Discov"},{"issue":"1","key":"293_CR85","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13256-023-04042-5","volume":"17","author":"A Behdadnia","year":"2023","unstructured":"Behdadnia A, Jeddi M. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report. J Med Case Rep. 2023;17(1):400. https:\/\/doi.org\/10.1186\/s13256-023-04042-5.","journal-title":"J Med Case Rep"},{"issue":"15","key":"293_CR86","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMcp2113128","volume":"386","author":"TA Guise","year":"2022","unstructured":"Guise TA, Wysolmerski JJ. Cancer-Associated Hypercalcemia. N Engl J Med. 2022;386(15):1443\u201351. https:\/\/doi.org\/10.1056\/NEJMcp2113128.","journal-title":"N Engl J Med"},{"key":"293_CR87","doi-asserted-by":"publisher","first-page":"1039490","DOI":"10.3389\/fendo.2023.1039490","volume":"14","author":"E Almuradova","year":"2023","unstructured":"Almuradova E, Cicin I. Cancer-related hypercalcemia and potential treatments. Front Endocrinol (Lausanne). 2023;14:1039490. https:\/\/doi.org\/10.3389\/fendo.2023.1039490.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"293_CR88","doi-asserted-by":"publisher","unstructured":"Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005;352(4):373\u20139. https:\/\/doi.org\/10.1056\/NEJMcp042806","DOI":"10.1056\/NEJMcp042806"},{"key":"293_CR89","doi-asserted-by":"publisher","unstructured":"Ramos REO, Perez Mak M, Alves MFS, Piotto GHM, Takahashi TK, Gomes da Fonseca L, et al. Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes. J Glob Oncol. 2017;3(6):728\u201333. https:\/\/doi.org\/10.1200\/JGO.2016.006890","DOI":"10.1200\/JGO.2016.006890"},{"issue":"3","key":"293_CR90","first-page":"246","volume":"11","author":"F Ashrafi","year":"2017","unstructured":"Ashrafi F, Iraj B, Nematollahi P, Darakhshandeh A. Pseudohypercalcemia in Multiple Myeloma: A Case Report. Int J Hematol Oncol Stem Cell Res. 2017;11(3):246\u20139.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"3","key":"293_CR91","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2353\/ajpath.2010.090610","volume":"176","author":"G Ciarimboli","year":"2010","unstructured":"Ciarimboli G, Deuster D, Knief A, Sperling M, Holtkamp M, Edemir B, et al. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol. 2010;176(3):1169\u201380. https:\/\/doi.org\/10.2353\/ajpath.2010.090610.","journal-title":"Am J Pathol"},{"issue":"4","key":"293_CR92","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/clpt.2009.139","volume":"86","author":"KK Filipski","year":"2009","unstructured":"Filipski KK, Mathijssen RH, Mikkelsen TS, Schinkel AH, Sparreboom A. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin Pharmacol Ther. 2009;86(4):396\u2013402. https:\/\/doi.org\/10.1038\/clpt.2009.139.","journal-title":"Clin Pharmacol Ther"},{"key":"293_CR93","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2147\/OTT.S86743","volume":"8","author":"T Mizuno","year":"2015","unstructured":"Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, et al. Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury. Onco Targets Ther. 2015;8:1701\u20136. https:\/\/doi.org\/10.2147\/OTT.S86743.","journal-title":"Onco Targets Ther"},{"key":"293_CR94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejphar.2017.05.034","volume":"811","author":"Y Saito","year":"2017","unstructured":"Saito Y, Okamoto K, Kobayashi M, Narumi K, Yamada T, Iseki K. Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters. Eur J Pharmacol. 2017;811:191\u20138. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.034.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"293_CR95","doi-asserted-by":"publisher","first-page":"F339","DOI":"10.1152\/ajprenal.00688.2016","volume":"313","author":"G Kumar","year":"2017","unstructured":"Kumar G, Solanki MH, Xue X, Mintz R, Madankumar S, Chatterjee PK, et al. Magnesium improves cisplatin-mediated tumor killing while protecting against cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol. 2017;313(2):F339\u201350. https:\/\/doi.org\/10.1152\/ajprenal.00688.2016.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"293_CR96","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41419-022-05104-0","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Guan Y, Zou J, Yang X, Bayliss G, Zhuang S. Histone methyltransferase MLL1 drives renal tubular cell apoptosis by p53-dependent repression of E-cadherin during cisplatin-induced acute kidney injury. Cell Death Dis. 2022;13(9):770. https:\/\/doi.org\/10.1038\/s41419-022-05104-0.","journal-title":"Cell Death Dis"},{"issue":"3","key":"293_CR97","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1158\/0008-5472.CAN-20-1010","volume":"81","author":"Y Hu","year":"2021","unstructured":"Hu Y, Yang C, Amorim T, Maqbool M, Lin J, Li C, et al. Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury. Cancer Res. 2021;81(3):713\u201323. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1010.","journal-title":"Cancer Res"},{"issue":"10","key":"293_CR98","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.7150\/thno.72456","volume":"12","author":"Q Yin","year":"2022","unstructured":"Yin Q, Zhao YJ, Ni WJ, Tang TT, Wang Y, Cao JY, et al. MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury. Theranostics. 2022;12(10):4753\u201366. https:\/\/doi.org\/10.7150\/thno.72456.","journal-title":"Theranostics"},{"issue":"19","key":"293_CR99","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1158\/1078-0432.CCR-06-1037","volume":"12","author":"Z Yang","year":"2006","unstructured":"Yang Z, Schumaker LM, Egorin MJ, Zuhowski EG, Guo Z, Cullen KJ. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin Cancer Res. 2006;12(19):5817\u201325. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1037.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"293_CR100","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/antiox10091329","volume":"10","author":"KA Mapuskar","year":"2021","unstructured":"Mapuskar KA, Steinbach EJ, Zaher A, Riley DP, Beardsley RA, Keene JL, et al. Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury. Antioxidants (Basel). 2021;10(9):1329. https:\/\/doi.org\/10.3390\/antiox10091329.","journal-title":"Antioxidants (Basel)."},{"issue":"7","key":"293_CR101","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/cancers13071572","volume":"13","author":"KR McSweeney","year":"2021","unstructured":"McSweeney KR, Gadanec LK, Qaradakhi T, Ali BA, Zulli A, Apostolopoulos V. Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. Cancers (Basel). 2021;13(7):1572. https:\/\/doi.org\/10.3390\/cancers13071572.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"293_CR102","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981\u201390. https:\/\/doi.org\/10.1016\/j.cellsig.2012.01.008.","journal-title":"Cell Signal"},{"issue":"1","key":"293_CR103","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41419-023-05557-x","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Shi X, Chen Z, Xu J, Zhao R, Liu Y, et al. Aldehyde dehydrogenase 2 alleviates mitochondrial dysfunction by promoting PGC-1alpha-mediated biogenesis in acute kidney injury. Cell Death Dis. 2023;14(1):45. https:\/\/doi.org\/10.1038\/s41419-023-05557-x.","journal-title":"Cell Death Dis"},{"issue":"3","key":"293_CR104","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/ijms24033028","volume":"24","author":"S Wang","year":"2023","unstructured":"Wang S, Chen Y, Wu H, Li X, Xiao H, Pan Q, et al. Role of Transcription Factor EB in Mitochondrial Dysfunction of Cisplatin-Induced Acute Kidney Injury. Int J Mol Sci. 2023;24(3):3028. https:\/\/doi.org\/10.3390\/ijms24033028.","journal-title":"Int J Mol Sci."},{"key":"293_CR105","doi-asserted-by":"publisher","unstructured":"Wang S, Zhu H, Li R, Mui D, Toan S, Chang X, et al. DNA-PKcs interacts with and phosphorylates Fis1 to induce mitochondrial fragmentation in tubular cells during acute kidney injury. Sci Signal. 2022;15(725):eabh1121. https:\/\/doi.org\/10.1126\/scisignal.abh1121","DOI":"10.1126\/scisignal.abh1121"},{"issue":"543","key":"293_CR106","doi-asserted-by":"publisher","first-page":"eaay7591","DOI":"10.1126\/scitranslmed.aay7591","volume":"12","author":"X Yu","year":"2020","unstructured":"Yu X, Xu M, Meng X, Li S, Liu Q, Bai M, et al. Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI. Sci Transl Med. 2020;12(543):eaay7591. https:\/\/doi.org\/10.1126\/scitranslmed.aay7591.","journal-title":"Sci Transl Med."},{"issue":"12","key":"293_CR107","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.3390\/molecules27123823","volume":"27","author":"M Zhou","year":"2022","unstructured":"Zhou M, Dai Y, Ma Y, Yan Y, Hua M, Gao Q, et al. Protective Effects of Liquiritigenin against Cisplatin-Induced Nephrotoxicity via NRF2\/SIRT3-Mediated Improvement of Mitochondrial Function. Molecules. 2022;27(12):3823. https:\/\/doi.org\/10.3390\/molecules27123823.","journal-title":"Molecules."},{"issue":"10","key":"293_CR108","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41419-023-06195-z","volume":"14","author":"W Xie","year":"2023","unstructured":"Xie W, He Q, Zhang Y, Xu X, Wen P, Cao H, et al. Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury. Cell Death Dis. 2023;14(10):663. https:\/\/doi.org\/10.1038\/s41419-023-06195-z.","journal-title":"Cell Death Dis"},{"issue":"4","key":"293_CR109","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.bbrc.2018.03.080","volume":"498","author":"K Tsushida","year":"2018","unstructured":"Tsushida K, Tanabe K, Masuda K, Tanimura S, Miyake H, Arata Y, et al. Estrogen-related receptor alpha is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury. Biochem Biophys Res Commun. 2018;498(4):918\u201324. https:\/\/doi.org\/10.1016\/j.bbrc.2018.03.080.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"293_CR110","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1681\/ASN.2017040381","volume":"29","author":"Y Guo","year":"2018","unstructured":"Guo Y, Ni J, Chen S, Bai M, Lin J, Ding G, et al. MicroRNA-709 Mediates Acute Tubular Injury through Effects on Mitochondrial Function. J Am Soc Nephrol. 2018;29(2):449\u201361. https:\/\/doi.org\/10.1681\/ASN.2017040381.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"293_CR111","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1111\/jcmm.15148","volume":"24","author":"M Li","year":"2020","unstructured":"Li M, Li CM, Ye ZC, Huang J, Li Y, Lai W, et al. Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice. J Cell Mol Med. 2020;24(9):5109\u201321. https:\/\/doi.org\/10.1111\/jcmm.15148.","journal-title":"J Cell Mol Med"},{"key":"293_CR112","doi-asserted-by":"publisher","first-page":"1097671","DOI":"10.3389\/fmed.2023.1097671","volume":"10","author":"HC Chen","year":"2023","unstructured":"Chen HC, Hou HY, Sung JM, Shieh CC. Deletion of NADPH oxidase 2 attenuates cisplatin-induced acute kidney injury through reducing ROS-induced proximal tubular cell injury and inflammation. Front Med (Lausanne). 2023;10:1097671. https:\/\/doi.org\/10.3389\/fmed.2023.1097671.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"293_CR113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/labinvest.2017.120","volume":"98","author":"XM Meng","year":"2018","unstructured":"Meng XM, Ren GL, Gao L, Yang Q, Li HD, Wu WF, et al. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation. Lab Invest. 2018;98(1):63\u201378. https:\/\/doi.org\/10.1038\/labinvest.2017.120.","journal-title":"Lab Invest"},{"issue":"11","key":"293_CR114","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.3390\/ijms24119448","volume":"24","author":"YN Chou","year":"2023","unstructured":"Chou YN, Lee MM, Deng JS, Jiang WP, Lin JG, Huang GJ. Water Extract from Brown Strain of Flammulina velutipes Alleviates Cisplatin-Induced Acute Kidney Injury by Attenuating Oxidative Stress, Inflammation, and Autophagy via PI3K\/AKT Pathway Regulation. Int J Mol Sci. 2023;24(11):9448. https:\/\/doi.org\/10.3390\/ijms24119448.","journal-title":"Int J Mol Sci."},{"key":"293_CR115","doi-asserted-by":"publisher","unstructured":"Huang W, Wang BO, Hou YF, Fu Y, Cui SJ, Zhu JH, et al. JAML promotes acute kidney injury mainly through a macrophage-dependent mechanism. JCI Insight. 2022;7(14):e158571. https:\/\/doi.org\/10.1172\/jci.insight.158571.","DOI":"10.1172\/jci.insight.158571"},{"issue":"2","key":"293_CR116","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7150\/ijbs.80200","volume":"19","author":"RZ Tan","year":"2023","unstructured":"Tan RZ, Li JC, Zhu BW, Huang XR, Wang HL, Jia J, et al. Neuropeptide Y protects kidney from acute kidney injury by inactivating M1 macrophages via the Y1R-NF-kappaB-Mincle-dependent mechanism. Int J Biol Sci. 2023;19(2):521\u201336. https:\/\/doi.org\/10.7150\/ijbs.80200.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"293_CR117","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3390\/biomedicines9080887","volume":"9","author":"CH Hsing","year":"2021","unstructured":"Hsing CH, Tsai CC, Chen CL, Lin YH, Tseng PC, Satria RD, et al. Pharmacologically Inhibiting Glycogen Synthase Kinase-3beta Ameliorates Renal Inflammation and Nephrotoxicity in an Animal Model of Cisplatin-Induced Acute Kidney Injury. Biomedicines. 2021;9(8):887. https:\/\/doi.org\/10.3390\/biomedicines9080887.","journal-title":"Biomedicines."},{"issue":"24","key":"293_CR118","doi-asserted-by":"publisher","first-page":"13304","DOI":"10.3390\/ijms222413304","volume":"22","author":"J Liu","year":"2021","unstructured":"Liu J, Yang DC, Zhang J, Hsu SW, Weiss RH, Chen CH. A Novel Renoprotective Strategy: Upregulation of PD-L1 Mitigates Cisplatin-Induced Acute Kidney Injury. Int J Mol Sci. 2021;22(24):13304. https:\/\/doi.org\/10.3390\/ijms222413304.","journal-title":"Int J Mol Sci."},{"key":"293_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109693","volume":"122","author":"P Liu","year":"2020","unstructured":"Liu P, Li X, Lv W, Xu Z. Inhibition of CXCL1-CXCR2 axis ameliorates cisplatin-induced acute kidney injury by mediating inflammatory response. Biomed Pharmacother. 2020;122: 109693. https:\/\/doi.org\/10.1016\/j.biopha.2019.109693.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"293_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1108","volume":"11","author":"A Gonzalez","year":"2023","unstructured":"Gonzalez A, Garcia-Gomez-Heras S, Franco-Rodriguez R, Lopez-Miranda V, Herradon E. Cisplatin cycles treatment sustains cardiovascular and renal damage involving TLR4 and NLRP3 pathways. Pharmacol Res Perspect. 2023;11(4): e01108. https:\/\/doi.org\/10.1002\/prp2.1108.","journal-title":"Pharmacol Res Perspect"},{"issue":"16","key":"293_CR121","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1042\/CS20170262","volume":"132","author":"M Andrade-Silva","year":"2018","unstructured":"Andrade-Silva M, Cenedeze MA, Perandini LA, Felizardo RJF, Watanabe IKM, Agudelo JSH, et al. TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury. Clin Sci (Lond). 2018;132(16):1725\u201339. https:\/\/doi.org\/10.1042\/CS20170262.","journal-title":"Clin Sci (Lond)"},{"issue":"20","key":"293_CR122","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.7150\/thno.33959","volume":"9","author":"V Volarevic","year":"2019","unstructured":"Volarevic V, Markovic BS, Jankovic MG, Djokovic B, Jovicic N, Harrell CR, et al. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1\/Kynurenine pathway in renal DCs. Theranostics. 2019;9(20):5976\u20136001. https:\/\/doi.org\/10.7150\/thno.33959.","journal-title":"Theranostics"},{"issue":"10","key":"293_CR123","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.ymthe.2018.07.014","volume":"26","author":"J Li","year":"2018","unstructured":"Li J, Tang Y, Tang PMK, Lv J, Huang XR, Carlsson-Skwirut C, et al. Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice. Mol Ther. 2018;26(10):2523\u201332. https:\/\/doi.org\/10.1016\/j.ymthe.2018.07.014.","journal-title":"Mol Ther"},{"issue":"19","key":"293_CR124","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.3390\/cells11192971","volume":"11","author":"Y Ding","year":"2022","unstructured":"Ding Y, Wan S, Liu W, Lu Y, Xu Q, Gan Y, et al. Regulation Networks of Non-Coding RNA-Associated ceRNAs in Cisplatin-Induced Acute Kidney Injury. Cells. 2022;11(19):2971. https:\/\/doi.org\/10.3390\/cells11192971.","journal-title":"Cells."},{"issue":"2","key":"293_CR125","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1042\/CS20190990","volume":"134","author":"Y Cao","year":"2020","unstructured":"Cao Y, Mi X, Zhang D, Wang Z, Zuo Y, Tang W. Transcriptome sequencing of circular RNA reveals a novel circular RNA-has_circ_0114427 in the regulation of inflammation in acute kidney injury. Clin Sci (Lond). 2020;134(2):139\u201354. https:\/\/doi.org\/10.1042\/CS20190990.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"293_CR126","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3892\/mmr.2019.10383","volume":"20","author":"C Zhang","year":"2019","unstructured":"Zhang C, Ma P, Zhao Z, Jiang N, Lian D, Huo P, et al. miRNA-mRNA regulatory network analysis of mesenchymal stem cell treatment in cisplatin-induced acute kidney injury identifies roles for miR-210\/Serpine1 and miR-378\/Fos in regulating inflammation. Mol Med Rep. 2019;20(2):1509\u201322. https:\/\/doi.org\/10.3892\/mmr.2019.10383.","journal-title":"Mol Med Rep"},{"issue":"1","key":"293_CR127","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/jcmm.13926","volume":"23","author":"H Soni","year":"2019","unstructured":"Soni H, Matthews AT, Pallikkuth S, Gangaraju R, Adebiyi A. gamma-secretase inhibitor DAPT mitigates cisplatin-induced acute kidney injury by suppressing Notch1 signaling. J Cell Mol Med. 2019;23(1):260\u201370. https:\/\/doi.org\/10.1111\/jcmm.13926.","journal-title":"J Cell Mol Med"},{"key":"293_CR128","doi-asserted-by":"crossref","unstructured":"Wang S, Zheng Y, Jin S, Fu Y, Liu Y. Dioscin Protects against Cisplatin-Induced Acute Kidney Injury by Reducing Ferroptosis and Apoptosis through Activating Nrf2\/HO-1 Signaling. Antioxidants (Basel). 2022;11(12):2443. https:\/\/doi.org\/10.3390\/antiox11122443.","DOI":"10.3390\/antiox11122443"},{"key":"293_CR129","doi-asserted-by":"publisher","unstructured":"Zhang X, Xu Y, Zhang W, Yang B, Zhang Y, Jia Z, et al. TRAF1 improves cisplatin-induced acute kidney injury via inhibition of inflammation and metabolic disorders. Biochim Biophys Acta Gen Subj. 2023;1867(9): 130423. https:\/\/doi.org\/10.1016\/j.bbagen.2023.1304230.","DOI":"10.1016\/j.bbagen.2023.1304230"},{"key":"293_CR130","doi-asserted-by":"publisher","unstructured":"Tan Z, Guo F, Huang Z, Xia Z, Liu J, Tao S, et al. Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury. J Cell Mol Med. 2019;23(9):6260\u201370. https:\/\/doi.org\/10.1111\/jcmm.14512.","DOI":"10.1111\/jcmm.14512"},{"key":"293_CR131","doi-asserted-by":"publisher","unstructured":"Loren P, Lugones Y, Saavedra N, Saavedra K, Paez I, Rodriguez N, et al. MicroRNAs Involved in Intrinsic Apoptotic Pathway during Cisplatin-Induced Nephrotoxicity: Potential Use of Natural Products against DDP-Induced Apoptosis. Biomolecules. 2022;12(9):1206. https:\/\/doi.org\/10.3390\/biom12091206.","DOI":"10.3390\/biom12091206"},{"key":"293_CR132","doi-asserted-by":"publisher","unstructured":"Xia Y, Pan W, Xiao X, Zhou X, Gu W, Liu Y, et al. MicroRNA-483-5p accentuates cisplatin-induced acute kidney injury by targeting GPX3. Lab Invest. 2022;102(6):589\u2013601. https:\/\/doi.org\/10.1038\/s41374-022-00737-3.","DOI":"10.1038\/s41374-022-00737-3"},{"key":"293_CR133","unstructured":"Xiong X, Tang B, Ji T, Li X, Bai S. Ameliorative effects of miR-186 on cisplatin-triggered acute kidney injury via targeting ZEB1. Am J Transl Res. 2021;13(5):4296\u2013308."},{"key":"293_CR134","doi-asserted-by":"publisher","unstructured":"Yang Y, Li ZL, Wang FM, Tang RN, Tu Y, Liu H. MicroRNA26a inhibits cisplatin-induced renal tubular epithelial cells apoptosis through suppressing the expression of transient receptor potential channel 6 mediated dynamin-related protein 1. Cell Biochem Funct. 2020;38(4):384\u201391. https:\/\/doi.org\/10.1002\/cbf.3474.","DOI":"10.1002\/cbf.3474"},{"key":"293_CR135","doi-asserted-by":"publisher","unstructured":"Mao W, Zhang L, Wang Y, Sun S, Wu J, Sun J, et al. Cisplatin induces acute kidney injury by downregulating miR-30e-5p that targets Galnt3 to activate the AMPK signaling pathway. Environ Toxicol. 2023. https:\/\/doi.org\/10.1002\/tox.24054.","DOI":"10.1002\/tox.24054"},{"key":"293_CR136","doi-asserted-by":"publisher","unstructured":"Ewees MGE, Orfali R, Rateb EE, Hassan HM, Hozzein WN, Alkhalfah DHM, et al. Modulation of mi-RNA25\/Ox-LDL\/NOX4 signaling pathway by polyphenolic compound Hydroxytyrosol as a new avenue to alleviate cisplatin-induced acute kidney injury, a mechanistic study in rats. Environ Toxicol Pharmacol. 2023;103: 104262. https:\/\/doi.org\/10.1016\/j.etap.2023.104262.","DOI":"10.1016\/j.etap.2023.104262"},{"key":"293_CR137","doi-asserted-by":"publisher","unstructured":"Wu J, Li DD, Li JY, Yin YC, Li PC, Qiu L, et al. Identification of microRNA-mRNA networks involved in cisplatin-induced renal tubular epithelial cells injury. Eur J Pharmacol. 2019;851:1\u201312. https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.015.","DOI":"10.1016\/j.ejphar.2019.02.015"},{"key":"293_CR138","doi-asserted-by":"publisher","unstructured":"Zhao Y, Lang Y, Zhang M, Liang S, Zhu X, Liu Z. miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury. Kidney Dis (Basel). 2022;8(2):137\u201347. https:\/\/doi.org\/10.1159\/000520140.","DOI":"10.1159\/000520140"},{"key":"293_CR139","doi-asserted-by":"crossref","unstructured":"Han S, Lin F, Ruan Y, Zhao S, Yuan R, Ning J, et al. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-kappaB pathway. Int Immunopharmacol. 2021;99: 108022.","DOI":"10.1016\/j.intimp.2021.108022"},{"key":"293_CR140","doi-asserted-by":"publisher","unstructured":"Yang A, Liu F, Guan B, Luo Z, Lin J, Fang W, et al. p53 induces miR-199a-3p to suppress mechanistic target of rapamycin activation in cisplatin-induced acute kidney injury. J Cell Biochem. 2019;120(10):17625\u201334. https:\/\/doi.org\/10.1002\/jcb.29030.","DOI":"10.1002\/jcb.29030"},{"key":"293_CR141","doi-asserted-by":"publisher","unstructured":"Qin W, Xie W, Yang X, Xia N, Yang K. Inhibiting microRNA-449 Attenuates Cisplatin-Induced Injury in NRK-52E Cells Possibly via Regulating the SIRT1\/P53\/BAX Pathway. Med Sci Monit. 2016;22:818\u201323. https:\/\/doi.org\/10.12659\/msm.897187.","DOI":"10.12659\/msm.897187"},{"key":"293_CR142","doi-asserted-by":"publisher","unstructured":"Sun W, Zhu Q, Yan L, Shao F. Mesenchymal stem cells alleviate acute kidney injury via miR-107-mediated regulation of ribosomal protein S19. Ann Transl Med. 2019;7(23):765. https:\/\/doi.org\/10.21037\/atm.2019.11.89.","DOI":"10.21037\/atm.2019.11.89"},{"key":"293_CR143","doi-asserted-by":"publisher","unstructured":"Sami DH, Soliman AS, Khowailed AA, Hassanein EHM, Kamel EM, Mahmoud AM. 7-hydroxycoumarin modulates Nrf2\/HO-1 and microRNA-34a\/SIRT1 signaling and prevents cisplatin-induced oxidative stress, inflammation, and kidney injury in rats. Life Sci. 2022;310: 121104. https:\/\/doi.org\/10.1016\/j.lfs.2022.121104.","DOI":"10.1016\/j.lfs.2022.121104"},{"key":"293_CR144","doi-asserted-by":"publisher","unstructured":"Chang S, Chang M, Liu G, Xu D, Wang H, Sun R, et al. LncRNA OIP5-AS1 reduces renal epithelial cell apoptosis in cisplatin-induced AKI by regulating the miR-144-5p\/PKM2 axis. Biomed J. 2022;45(4):642\u201353. https:\/\/doi.org\/10.1016\/j.bj.2021.07.005.","DOI":"10.1016\/j.bj.2021.07.005"},{"key":"293_CR145","doi-asserted-by":"publisher","unstructured":"Li J, Fan X, Wang Q, Gong Y, Guo L. Long Noncoding RNA PRNCR1 Reduces Renal Epithelial Cell Apoptosis in Cisplatin-Induced AKI by Regulating miR-182-5p\/EZH1. Kidney Blood Press Res. 2021;46(2):162\u201372. https:\/\/doi.org\/10.1159\/000510157.","DOI":"10.1159\/000510157"},{"issue":"2","key":"293_CR146","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/ki.2012.64","volume":"82","author":"J Kim","year":"2012","unstructured":"Kim J, Long KE, Tang K, Padanilam BJ. Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity. Kidney Int. 2012;82(2):193\u2013203. https:\/\/doi.org\/10.1038\/ki.2012.64.","journal-title":"Kidney Int"},{"key":"293_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153202","volume":"69","author":"WF Wu","year":"2020","unstructured":"Wu WF, Wang JN, Li Z, Wei B, Jin J, Gao L, et al. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation. Phytomedicine. 2020;69: 153202. https:\/\/doi.org\/10.1016\/j.phymed.2020.153202.","journal-title":"Phytomedicine"},{"key":"293_CR148","doi-asserted-by":"publisher","unstructured":"Zhang S, Sun H, Kong W, Zhang B. Functional role of microRNA-500a-3P-loaded liposomes in the treatment of cisplatin-induced AKI. IET Nanobiotechnol. 2020;14(6):465\u20139. https:\/\/doi.org\/10.1049\/iet-nbt.2019.0247.","DOI":"10.1049\/iet-nbt.2019.0247"},{"key":"293_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105789","volume":"206","author":"S Jiang","year":"2021","unstructured":"Jiang S, Zhang H, Li X, Yi B, Huang L, Hu Z, et al. Vitamin D\/VDR attenuate cisplatin-induced AKI by down-regulating NLRP3\/Caspase-1\/GSDMD pyroptosis pathway. J Steroid Biochem Mol Biol. 2021;206: 105789. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105789.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"293_CR150","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.2147\/JIR.S427505","volume":"16","author":"J Liu","year":"2023","unstructured":"Liu J, Han X, Zhou J, Leng Y. Molecular Mechanisms of Ferroptosis and Their Involvement in Acute Kidney Injury. J Inflamm Res. 2023;16:4941\u201351. https:\/\/doi.org\/10.2147\/JIR.S427505.","journal-title":"J Inflamm Res"},{"key":"293_CR151","doi-asserted-by":"publisher","unstructured":"Ma Y, Huang L, Zhang Z, Yang P, Chen Q, Zeng X, et al. CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury. Genes Dis. 2024;11(1):449\u201363. https:\/\/doi.org\/10.1016\/j.gendis.2022.12.003.","DOI":"10.1016\/j.gendis.2022.12.003"},{"key":"293_CR152","doi-asserted-by":"publisher","unstructured":"Yang M, Liu YT, Han YC, Zhang W, Zhang H, Yang S. Mitochondrial Translocation of P66Shc Aggravates Cisplatin-induced AKI by Promoting Ferroptosis. Curr Med Chem. 2023;30(6):744\u201356. https:\/\/doi.org\/10.2174\/0929867329666220819112808.","DOI":"10.2174\/0929867329666220819112808"},{"key":"293_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102826","volume":"65","author":"Z Deng","year":"2023","unstructured":"Deng Z, Wang Y, Liu J, Zhang H, Zhou L, Zhao H, et al. WBP2 restrains the lysosomal degradation of GPX4 to inhibit ferroptosis in cisplatin-induced acute kidney injury. Redox Biol. 2023;65: 102826. https:\/\/doi.org\/10.1016\/j.redox.2023.102826.","journal-title":"Redox Biol"},{"issue":"1","key":"293_CR154","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s10020-023-00733-3","volume":"29","author":"Q Gong","year":"2023","unstructured":"Gong Q, Lai T, Liang L, Jiang Y, Liu F. Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury. Mol Med. 2023;29(1):140. https:\/\/doi.org\/10.1186\/s10020-023-00733-3.","journal-title":"Mol Med"},{"key":"293_CR155","doi-asserted-by":"publisher","unstructured":"Zeng F, Nijiati S, Liu Y, Yang Q, Liu X, Zhang Q, et al. Ferroptosis MRI for early detection of anticancer drug-induced acute cardiac\/kidney injuries. Sci Adv. 2023;9(10):eadd8539. https:\/\/doi.org\/10.1126\/sciadv.add8539","DOI":"10.1126\/sciadv.add8539"},{"key":"293_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112672","volume":"158","author":"M Yu","year":"2021","unstructured":"Yu M, Lin Z, Tian X, Chen S, Liang X, Qin M, et al. Downregulation of Cx43 reduces cisplatin-induced acute renal injury by inhibiting ferroptosis. Food Chem Toxicol. 2021;158: 112672. https:\/\/doi.org\/10.1016\/j.fct.2021.112672.","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"293_CR157","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1681\/ASN.2016070744","volume":"28","author":"RK Dutta","year":"2017","unstructured":"Dutta RK, Kondeti VK, Sharma I, Chandel NS, Quaggin SE, Kanwar YS. Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI. J Am Soc Nephrol. 2017;28(5):1421\u201336. https:\/\/doi.org\/10.1681\/ASN.2016070744.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"293_CR158","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1172\/JCI129903","volume":"129","author":"F Deng","year":"2019","unstructured":"Deng F, Sharma I, Dai Y, Yang M, Kanwar YS. Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule. J Clin Invest. 2019;129(11):5033\u201349. https:\/\/doi.org\/10.1172\/JCI129903.","journal-title":"J Clin Invest"},{"issue":"1","key":"293_CR159","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41419-020-2256-z","volume":"11","author":"Z Hu","year":"2020","unstructured":"Hu Z, Zhang H, Yi B, Yang S, Liu J, Hu J, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell Death Dis. 2020;11(1):73. https:\/\/doi.org\/10.1038\/s41419-020-2256-z.","journal-title":"Cell Death Dis"},{"key":"293_CR160","doi-asserted-by":"publisher","unstructured":"Zhou J, Xiao C, Zheng S, Wang Q, Zhu H, Zhang Y, et al. MicroRNA-214-3p aggravates ferroptosis by targeting GPX4 in cisplatin-induced acute kidney injury. Cell Stress Chaperones. 2022;27(4):325\u201336. https:\/\/doi.org\/10.1007\/s12192-022-01271-3.","DOI":"10.1007\/s12192-022-01271-3"},{"key":"293_CR161","doi-asserted-by":"publisher","first-page":"1103062","DOI":"10.3389\/fphar.2023.1103062","volume":"14","author":"N Alassaf","year":"2023","unstructured":"Alassaf N, Attia H. Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential. Front Pharmacol. 2023;14:1103062. https:\/\/doi.org\/10.3389\/fphar.2023.1103062.","journal-title":"Front Pharmacol"},{"issue":"8","key":"293_CR162","doi-asserted-by":"publisher","first-page":"F1239","DOI":"10.1152\/ajprenal.00659.2011","volume":"303","author":"C Herzog","year":"2012","unstructured":"Herzog C, Yang C, Holmes A, Kaushal GP. zVAD-fmk prevents cisplatin-induced cleavage of autophagy proteins but impairs autophagic flux and worsens renal function. Am J Physiol Renal Physiol. 2012;303(8):F1239\u201350. https:\/\/doi.org\/10.1152\/ajprenal.00659.2011.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"293_CR163","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/15548627.2022.2084862","volume":"19","author":"L Su","year":"2023","unstructured":"Su L, Zhang J, Gomez H, Kellum JA, Peng Z. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2023;19(2):401\u201314. https:\/\/doi.org\/10.1080\/15548627.2022.2084862.","journal-title":"Autophagy"},{"issue":"2","key":"293_CR164","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.yexcr.2016.12.015","volume":"350","author":"C Zhao","year":"2017","unstructured":"Zhao C, Chen Z, Xu X, An X, Duan S, Huang Z, et al. Pink1\/Parkin-mediated mitophagy play a protective role in cisplatin induced renal tubular epithelial cells injury. Exp Cell Res. 2017;350(2):390\u20137. https:\/\/doi.org\/10.1016\/j.yexcr.2016.12.015.","journal-title":"Exp Cell Res"},{"key":"293_CR165","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3389\/fphys.2019.01225","volume":"10","author":"L Zhou","year":"2019","unstructured":"Zhou L, Zhang L, Zhang Y, Yu X, Sun X, Zhu T, et al. PINK1 Deficiency Ameliorates Cisplatin-Induced Acute Kidney Injury in Rats. Front Physiol. 2019;10:1225. https:\/\/doi.org\/10.3389\/fphys.2019.01225.","journal-title":"Front Physiol"},{"issue":"3","key":"293_CR166","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1002\/jcb.27722","volume":"120","author":"Q Shen","year":"2019","unstructured":"Shen Q, Zhang X, Li Q, Zhang J, Lai H, Gan H, et al. TLR2 protects cisplatin-induced acute kidney injury associated with autophagy via PI3K\/Akt signaling pathway. J Cell Biochem. 2019;120(3):4366\u201374. https:\/\/doi.org\/10.1002\/jcb.27722.","journal-title":"J Cell Biochem"},{"issue":"7","key":"293_CR167","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1080\/10715762.2019.1635251","volume":"53","author":"W Liao","year":"2019","unstructured":"Liao W, Wang Z, Fu Z, Ma H, Jiang M, Xu A, et al. p62\/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway. Free Radic Res. 2019;53(7):800\u201314. https:\/\/doi.org\/10.1080\/10715762.2019.1635251.","journal-title":"Free Radic Res"},{"key":"293_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113939","volume":"177","author":"JY Kim","year":"2020","unstructured":"Kim JY, Jayne LA, Bai Y, Feng M, Clark MA, Chung S, et al. Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms. Biochem Pharmacol. 2020;177: 113939. https:\/\/doi.org\/10.1016\/j.bcp.2020.113939.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"293_CR169","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00467-022-05532-2","volume":"37","author":"X Lin","year":"2022","unstructured":"Lin X, Jin H, Chai Y, Shou S. Cellular senescence and acute kidney injury. Pediatr Nephrol. 2022;37(12):3009\u201318. https:\/\/doi.org\/10.1007\/s00467-022-05532-2.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"293_CR170","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41392-022-01254-x","volume":"7","author":"L Yang","year":"2022","unstructured":"Yang L, Wang B, Guo F, Huang R, Liang Y, Li L, et al. FFAR4 improves the senescence of tubular epithelial cells by AMPK\/SirT3 signaling in acute kidney injury. Signal Transduct Target Ther. 2022;7(1):384. https:\/\/doi.org\/10.1038\/s41392-022-01254-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"293_CR171","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41419-022-05492-3","volume":"14","author":"L Wen","year":"2023","unstructured":"Wen L, Ren Q, Guo F, Du X, Yang H, Fu P, et al. Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury. Cell Death Dis. 2023;14(1):18. https:\/\/doi.org\/10.1038\/s41419-022-05492-3.","journal-title":"Cell Death Dis"},{"issue":"25","key":"293_CR172","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1200\/JCO.2009.25.4540","volume":"28","author":"BC Widemann","year":"2010","unstructured":"Widemann BC, Balis FM, Kim A, Boron M, Jayaprakash N, Shalabi A, et al. Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome. J Clin Oncol. 2010;28(25):3979\u201386. https:\/\/doi.org\/10.1200\/JCO.2009.25.4540.","journal-title":"J Clin Oncol"},{"issue":"2","key":"293_CR173","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/1060028013511951","volume":"48","author":"E Bain","year":"2014","unstructured":"Bain E, Birhiray RE, Reeves DJ. Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination. Ann Pharmacother. 2014;48(2):292\u20136. https:\/\/doi.org\/10.1177\/1060028013511951.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"293_CR174","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/phar.2516","volume":"41","author":"CE DeFino","year":"2021","unstructured":"DeFino CE, Barreto JN, Pawlenty AG, Ruff MW, Carabenciov ID, Mara KC, et al. Lack of drug interaction between levetiracetam and high-dose methotrexate in patients with lymphoma. Pharmacotherapy. 2021;41(5):430\u20139. https:\/\/doi.org\/10.1002\/phar.2516.","journal-title":"Pharmacotherapy"},{"issue":"17","key":"293_CR175","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.3390\/cancers14174086","volume":"14","author":"M Borowka","year":"2022","unstructured":"Borowka M, Lacki-Zynzeling S, Nicze M, Kozak S, Chudek J. Adverse Renal Effects of Anticancer Immunotherapy: A Review. Cancers (Basel). 2022;14(17):4086. https:\/\/doi.org\/10.3390\/cancers14174086.","journal-title":"Cancers (Basel)."},{"key":"293_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.574271","volume":"11","author":"R Franzin","year":"2020","unstructured":"Franzin R, Netti GS, Spadaccino F, Porta C, Gesualdo L, Stallone G, et al. The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand? Front Immunol. 2020;11: 574271. https:\/\/doi.org\/10.3389\/fimmu.2020.574271.","journal-title":"Front Immunol"},{"issue":"1","key":"293_CR177","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","volume":"8","author":"Q Sun","year":"2023","unstructured":"Sun Q, Hong Z, Zhang C, Wang L, Han Z, Ma D. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. Signal Transduct Target Ther. 2023;8(1):320. https:\/\/doi.org\/10.1038\/s41392-023-01522-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"293_CR178","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41581-022-00630-8","volume":"18","author":"B Sprangers","year":"2022","unstructured":"Sprangers B, Leaf DE, Porta C, Soler MJ, Perazella MA. Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury. Nat Rev Nephrol. 2022;18(12):794\u2013805. https:\/\/doi.org\/10.1038\/s41581-022-00630-8.","journal-title":"Nat Rev Nephrol"},{"issue":"24","key":"293_CR179","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.3390\/cells11243991","volume":"11","author":"A Joseph","year":"2022","unstructured":"Joseph A, Lafarge A, Azoulay E, Zafrani L. Acute Kidney Injury in Cancer Immunotherapy Recipients. Cells. 2022;11(24):3991. https:\/\/doi.org\/10.3390\/cells11243991.","journal-title":"Cells."},{"issue":"1","key":"293_CR180","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1053\/j.ajkd.2019.10.011","volume":"76","author":"S Gupta","year":"2020","unstructured":"Gupta S, Seethapathy H, Strohbehn IA, Frigault MJ, O\u2019Donnell EK, Jacobson CA, et al. Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma. Am J Kidney Dis. 2020;76(1):63\u201371. https:\/\/doi.org\/10.1053\/j.ajkd.2019.10.011.","journal-title":"Am J Kidney Dis"},{"key":"293_CR181","doi-asserted-by":"publisher","unstructured":"Wu S, Lu J, Su D, Yang F, Zhang Y, Hu S. The advantage of chimeric antigen receptor T cell therapy in pediatric acute lymphoblastic leukemia with E2A-HLF fusion gene positivity: a case series. Transl Pediatr. 2021;10(3):686\u201391. https:\/\/doi.org\/10.21037\/tp-20-323","DOI":"10.21037\/tp-20-323"},{"issue":"5","key":"293_CR182","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2215\/CJN.12871117","volume":"13","author":"KD Jhaveri","year":"2018","unstructured":"Jhaveri KD, Rosner MH. Chimeric Antigen Receptor T Cell Therapy and the Kidney: What the Nephrologist Needs to Know. Clin J Am Soc Nephrol. 2018;13(5):796\u20138. https:\/\/doi.org\/10.2215\/CJN.12871117.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"293_CR183","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, et al. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol. 2018;15(1):47\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.148.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"293_CR184","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1681\/ASN.2018050488","volume":"29","author":"MA Perazella","year":"2018","unstructured":"Perazella MA, Shirali AC. Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future. J Am Soc Nephrol. 2018;29(8):2039\u201352. https:\/\/doi.org\/10.1681\/ASN.2018050488.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"293_CR185","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41581-018-0035-1","volume":"14","author":"K Sury","year":"2018","unstructured":"Sury K, Perazella MA, Shirali AC. Cardiorenal complications of immune checkpoint inhibitors. Nat Rev Nephrol. 2018;14(9):571\u201388. https:\/\/doi.org\/10.1038\/s41581-018-0035-1.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"293_CR186","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.it.2015.12.005","volume":"37","author":"DM Richards","year":"2016","unstructured":"Richards DM, Kyewski B, Feuerer M. Re-examining the Nature and Function of Self-Reactive T cells. Trends Immunol. 2016;37(2):114\u201325. https:\/\/doi.org\/10.1016\/j.it.2015.12.005.","journal-title":"Trends Immunol"},{"issue":"3","key":"293_CR187","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ekir.2022.11.020","volume":"8","author":"N Farooqui","year":"2023","unstructured":"Farooqui N, Zaidi M, Vaughan L, McKee TD, Ahsan E, Pavelko KD, et al. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors. Kidney Int Rep. 2023;8(3):628\u201341. https:\/\/doi.org\/10.1016\/j.ekir.2022.11.020.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"293_CR188","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12882-022-02999-x","volume":"23","author":"K Kohatsu","year":"2022","unstructured":"Kohatsu K, Suzuki T, Takimoto M, Matsui K, Hashiguchi A, Koike J, et al. Granulomatous interstitial nephritis with CTLA-4 haploinsufficiency: a case report. BMC Nephrol. 2022;23(1):367. https:\/\/doi.org\/10.1186\/s12882-022-02999-x.","journal-title":"BMC Nephrol"},{"issue":"1","key":"293_CR189","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4049\/jimmunol.1400497","volume":"194","author":"K Jaworska","year":"2015","unstructured":"Jaworska K, Ratajczak J, Huang L, Whalen K, Yang M, Stevens BK, et al. Both PD-1 ligands protect the kidney from ischemia reperfusion injury. J Immunol. 2015;194(1):325\u201333. https:\/\/doi.org\/10.4049\/jimmunol.1400497.","journal-title":"J Immunol"},{"issue":"1","key":"293_CR190","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/ndt\/gfy105","volume":"34","author":"S Manohar","year":"2019","unstructured":"Manohar S, Kompotiatis P, Thongprayoon C, Cheungpasitporn W, Herrmann J, Herrmann SM. Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis. Nephrol Dial Transplant. 2019;34(1):108\u201317. https:\/\/doi.org\/10.1093\/ndt\/gfy105.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"293_CR191","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/ckj\/sfw024","volume":"9","author":"N Murakami","year":"2016","unstructured":"Murakami N, Borges TJ, Yamashita M, Riella LV. Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma. Clin Kidney J. 2016;9(3):411\u20137. https:\/\/doi.org\/10.1093\/ckj\/sfw024.","journal-title":"Clin Kidney J"},{"issue":"1","key":"293_CR192","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12882-018-0848-y","volume":"19","author":"R Koda","year":"2018","unstructured":"Koda R, Watanabe H, Tsuchida M, Iino N, Suzuki K, Hasegawa G, et al. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report. BMC Nephrol. 2018;19(1):48. https:\/\/doi.org\/10.1186\/s12882-018-0848-y.","journal-title":"BMC Nephrol"},{"issue":"4","key":"293_CR193","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.ajkd.2019.03.433","volume":"74","author":"R Shingarev","year":"2019","unstructured":"Shingarev R, Glezerman IG. Kidney Complications of Immune Checkpoint Inhibitors: A Review. Am J Kidney Dis. 2019;74(4):529\u201337. https:\/\/doi.org\/10.1053\/j.ajkd.2019.03.433.","journal-title":"Am J Kidney Dis"},{"key":"293_CR194","doi-asserted-by":"publisher","unstructured":"Marco T, Anna P, Annalisa T, Francesco M, Stefania SL, Stella D, et al. The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. Ther Adv Med Oncol. 2019;11:1758835919875549. https:\/\/doi.org\/10.1177\/1758835919875549.","DOI":"10.1177\/1758835919875549"},{"issue":"2","key":"293_CR195","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMc0904283","volume":"361","author":"F Fadel","year":"2009","unstructured":"Fadel F, El Karoui K, Knebelmann B. Anti-CTLA4 antibody-induced lupus nephritis. N Engl J Med. 2009;361(2):211\u20132. https:\/\/doi.org\/10.1056\/NEJMc0904283.","journal-title":"N Engl J Med"},{"issue":"3","key":"293_CR196","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","volume":"11","author":"G Redelman-Sidi","year":"2014","unstructured":"Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer\u2013a current perspective. Nat Rev Urol. 2014;11(3):153\u201362. https:\/\/doi.org\/10.1038\/nrurol.2014.15.","journal-title":"Nat Rev Urol"},{"key":"293_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102169","volume":"88","author":"Z Kattih","year":"2025","unstructured":"Kattih Z, Iacono A, Saikus C, Esposito M, Kon Z, Korotun M. Tacrolimus-induced thrombotic microangiopathy (TMA) after heart and lung transplantation successfully treated with eculizumab. Transpl Immunol. 2025;88: 102169. https:\/\/doi.org\/10.1016\/j.trim.2024.102169.","journal-title":"Transpl Immunol"},{"issue":"11","key":"293_CR198","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000791","volume":"6","author":"P Efentakis","year":"2022","unstructured":"Efentakis P, Lamprou S, Makridakis M, Barla I, Nikolaou PE, Christodoulou A, et al. Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of Eplerenone. Hemasphere. 2022;6(11): e791. https:\/\/doi.org\/10.1097\/HS9.0000000000000791.","journal-title":"Hemasphere"},{"issue":"13","key":"293_CR199","doi-asserted-by":"publisher","first-page":"10621","DOI":"10.3390\/ijms241310621","volume":"24","author":"MM Qadri","year":"2023","unstructured":"Qadri MM, Alam MF, Khired ZA, Alaqi RO, Khardali AA, Alasmari MM, et al. Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory\/Apoptotic Mediators, and Augmenting Nrf2 in Rats. Int J Mol Sci. 2023;24(13):10621. https:\/\/doi.org\/10.3390\/ijms241310621.","journal-title":"Int J Mol Sci."},{"issue":"22","key":"293_CR200","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.3390\/molecules27227929","volume":"27","author":"I Barla","year":"2022","unstructured":"Barla I, Efentakis P, Lamprou S, Gavriatopoulou M, Dimopoulos MA, Terpos E, et al. An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity. Molecules. 2022;27(22):7929. https:\/\/doi.org\/10.3390\/molecules27227929.","journal-title":"Molecules."},{"key":"293_CR201","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","volume":"53","author":"KM Morrissey","year":"2013","unstructured":"Morrissey KM, Stocker SL, Wittwer MB, Xu L, Giacomini KM. Renal transporters in drug development. Annu Rev Pharmacol Toxicol. 2013;53:503\u201329. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140317.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"293_CR202","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1124\/dmd.113.053215","volume":"41","author":"H Shen","year":"2013","unstructured":"Shen H, Yang Z, Zhao W, Zhang Y, Rodrigues AD. Assessment of vandetanib as an inhibitor of various human renal transporters: inhibition of multidrug and toxin extrusion as a possible mechanism leading to decreased cisplatin and creatinine clearance. Drug Metab Dispos. 2013;41(12):2095\u2013103. https:\/\/doi.org\/10.1124\/dmd.113.053215.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"293_CR203","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/ckj\/sfv149","volume":"9","author":"R Wanchoo","year":"2016","unstructured":"Wanchoo R, Jhaveri KD, Deray G, Launay-Vacher V. Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network. Clin Kidney J. 2016;9(2):245\u201351. https:\/\/doi.org\/10.1093\/ckj\/sfv149.","journal-title":"Clin Kidney J"},{"issue":"8","key":"293_CR204","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/ckj\/sfac062","volume":"15","author":"M Bonilla","year":"2022","unstructured":"Bonilla M, Jhaveri KD, Izzedine H. Anaplastic lymphoma kinase inhibitors and their effect on the kidney. Clin Kidney J. 2022;15(8):1475\u201382. https:\/\/doi.org\/10.1093\/ckj\/sfac062.","journal-title":"Clin Kidney J"},{"issue":"9","key":"293_CR205","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.humpath.2014.05.015","volume":"45","author":"IG Glezerman","year":"2014","unstructured":"Glezerman IG, Salvatore SP, Chandran CB, Flombaum CD, Seshan SV. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature. Hum Pathol. 2014;45(9):1918\u201327. https:\/\/doi.org\/10.1016\/j.humpath.2014.05.015.","journal-title":"Hum Pathol"},{"key":"293_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111779","volume":"132","author":"Q Ma","year":"2024","unstructured":"Ma Q, Zheng L, Cheng H, Li X, Liu Z, Gong P. PDCD4-induced oxidative stress through FGR\/NF-kappaB axis in rectal cancer radiotherapy-induced AKI. Int Immunopharmacol. 2024;132: 111779. https:\/\/doi.org\/10.1016\/j.intimp.2024.111779.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"293_CR207","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12967-023-04548-y","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, Zhang S, He Z, Chen Y. Cytosine-phosphate-guanine oligodeoxynucleotides alleviate radiation-induced kidney injury in cervical cancer by inhibiting DNA damage and oxidative stress through blockade of PARP1\/XRCC1 axis. J Transl Med. 2023;21(1):679. https:\/\/doi.org\/10.1186\/s12967-023-04548-y.","journal-title":"J Transl Med"},{"key":"293_CR208","doi-asserted-by":"publisher","unstructured":"Mahran YF, Al-Kharashi LA, Atawia RT, Alanazi RT, Dhahi AMB, Alsubaie R, et al. Radioprotective Effects of Carvacrol and\/or Thymol against Gamma Irradiation-Induced Acute Nephropathy: In Silico and In Vivo Evidence of the Involvement of Insulin-like Growth Factor-1 (IGF-1) and Calcitonin Gene-Related Peptide. Biomedicines. 2023;11(9):2521. https:\/\/doi.org\/10.3390\/biomedicines11092521","DOI":"10.3390\/biomedicines11092521"},{"key":"293_CR209","doi-asserted-by":"publisher","first-page":"34682","DOI":"10.1038\/srep34682","volume":"6","author":"J Shen","year":"2016","unstructured":"Shen J, Wang L, Jiang N, Mou S, Zhang M, Gu L, et al. NLRP3 inflammasome mediates contrast media-induced acute kidney injury by regulating cell apoptosis. Sci Rep. 2016;6:34682. https:\/\/doi.org\/10.1038\/srep34682.","journal-title":"Sci Rep"},{"issue":"18","key":"293_CR210","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367(18):1694\u2013703. https:\/\/doi.org\/10.1056\/NEJMoa1210093.","journal-title":"N Engl J Med"},{"issue":"1","key":"293_CR211","doi-asserted-by":"publisher","first-page":"2178821","DOI":"10.1080\/0886022X.2023.2178821","volume":"45","author":"YH Deng","year":"2023","unstructured":"Deng YH, Wang XF, Wu X, Yan P, Liu Q, Wu T, et al. Differential renal proteomics analysis in a novel rat model of iodinated contrast-induced acute kidney injury. Ren Fail. 2023;45(1):2178821. https:\/\/doi.org\/10.1080\/0886022X.2023.2178821.","journal-title":"Ren Fail"},{"issue":"1","key":"293_CR212","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13054-024-04998-w","volume":"28","author":"F Bidar","year":"2024","unstructured":"Bidar F, Peillon L, Bodinier M, Venet F, Monneret G, Lukaszewicz AC, et al. Immune profiling of critically ill patients with acute kidney injury during the first week after various types of injuries: the REALAKI study. Crit Care. 2024;28(1):227. https:\/\/doi.org\/10.1186\/s13054-024-04998-w.","journal-title":"Crit Care"},{"issue":"12","key":"293_CR213","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41581-024-00875-5","volume":"20","author":"K Lee","year":"2024","unstructured":"Lee K, Jang HR, Rabb H. Lymphocytes and innate immune cells in acute kidney injury and repair. Nat Rev Nephrol. 2024;20(12):789\u2013805. https:\/\/doi.org\/10.1038\/s41581-024-00875-5.","journal-title":"Nat Rev Nephrol"},{"key":"293_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-025-00958-x","author":"XM Meng","year":"2025","unstructured":"Meng XM, Wang L, Nikolic-Paterson DJ, Lan HY. Innate immune cells in acute and chronic kidney disease. Nat Rev Nephrol. 2025. https:\/\/doi.org\/10.1038\/s41581-025-00958-x.","journal-title":"Nat Rev Nephrol"},{"key":"293_CR215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2025.02.003","volume":"278","author":"YF Mu","year":"2025","unstructured":"Mu YF, Mao ZH, Pan SK, Liu DW, Liu ZS, Wu P, et al. Macrophage-driven inflammation in acute kidney injury: Therapeutic opportunities and challenges. Transl Res. 2025;278:1\u20139. https:\/\/doi.org\/10.1016\/j.trsl.2025.02.003.","journal-title":"Transl Res"},{"key":"293_CR216","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934299","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen H, Liu N, Zhuang S. Macrophages in Renal Injury, Repair, Fibrosis Following Acute Kidney Injury and Targeted Therapy. Front Immunol. 2022;13: 934299. https:\/\/doi.org\/10.3389\/fimmu.2022.934299.","journal-title":"Front Immunol"},{"issue":"2","key":"293_CR217","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nm.4462","volume":"24","author":"K Okubo","year":"2018","unstructured":"Okubo K, Kurosawa M, Kamiya M, Urano Y, Suzuki A, Yamamoto K, et al. Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury. Nat Med. 2018;24(2):232\u20138. https:\/\/doi.org\/10.1038\/nm.4462.","journal-title":"Nat Med"},{"key":"293_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111417","volume":"127","author":"Y Peng","year":"2024","unstructured":"Peng Y, Fang Y, Li Z, Liu C, Zhang W. Saa3 promotes pro-inflammatory macrophage differentiation and contributes to sepsis-induced AKI. Int Immunopharmacol. 2024;127: 111417. https:\/\/doi.org\/10.1016\/j.intimp.2023.111417.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"293_CR219","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.ekir.2019.09.003","volume":"4","author":"DG Moledina","year":"2019","unstructured":"Moledina DG, Mansour SG, Jia Y, Obeid W, Thiessen-Philbrook H, Koyner JL, et al. Association of T Cell-Derived Inflammatory Cytokines With Acute Kidney Injury and Mortality After Cardiac Surgery. Kidney Int Rep. 2019;4(12):1689\u201397. https:\/\/doi.org\/10.1016\/j.ekir.2019.09.003.","journal-title":"Kidney Int Rep"},{"key":"293_CR220","doi-asserted-by":"publisher","unstructured":"Lau A, Rahn JJ, Chappellaz M, Chung H, Benediktsson H, Bihan D, et al. Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury. Sci Adv. 2022;8(5):eabm0142. https:\/\/doi.org\/10.1126\/sciadv.abm0142","DOI":"10.1126\/sciadv.abm0142"},{"issue":"2","key":"293_CR221","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.kint.2023.04.013","volume":"104","author":"S Li","year":"2023","unstructured":"Li S, Zhang Y, Lu R, Lv X, Lei Q, Tang D, et al. Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle\/Syk\/NF-kappaB signaling. Kidney Int. 2023;104(2):305\u201323. https:\/\/doi.org\/10.1016\/j.kint.2023.04.013.","journal-title":"Kidney Int"},{"key":"293_CR222","doi-asserted-by":"publisher","first-page":"1487576","DOI":"10.3389\/fimmu.2024.1487576","volume":"15","author":"AB Liu","year":"2024","unstructured":"Liu AB, Tan B, Yang P, Tian N, Li JK, Wang SC, et al. The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential. Front Immunol. 2024;15:1487576. https:\/\/doi.org\/10.3389\/fimmu.2024.1487576.","journal-title":"Front Immunol"},{"issue":"4","key":"293_CR223","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.7150\/thno.50905","volume":"11","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang Y, Li L, Liu S, Wang C, Yuan Y, et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics. 2021;11(4):1845\u201363. https:\/\/doi.org\/10.7150\/thno.50905.","journal-title":"Theranostics"},{"key":"293_CR224","doi-asserted-by":"publisher","first-page":"1490725","DOI":"10.3389\/fphys.2024.1490725","volume":"15","author":"K Deng","year":"2024","unstructured":"Deng K, Pei M, Li B, Yang N, Wang Z, Wan X, et al. Signal pathways involved in contrast-induced acute kidney injury. Front Physiol. 2024;15:1490725. https:\/\/doi.org\/10.3389\/fphys.2024.1490725.","journal-title":"Front Physiol"},{"key":"293_CR225","doi-asserted-by":"publisher","first-page":"1335094","DOI":"10.3389\/fphar.2023.1335094","volume":"14","author":"N Ren","year":"2023","unstructured":"Ren N, Wang WF, Zou L, Zhao YL, Miao H, Zhao YY. The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis. Front Pharmacol. 2023;14:1335094. https:\/\/doi.org\/10.3389\/fphar.2023.1335094.","journal-title":"Front Pharmacol"},{"issue":"5","key":"293_CR226","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","volume":"19","author":"AB Sanz","year":"2023","unstructured":"Sanz AB, Sanchez-Nino MD, Ramos AM, Ortiz A. Regulated cell death pathways in kidney disease. Nat Rev Nephrol. 2023;19(5):281\u201399. https:\/\/doi.org\/10.1038\/s41581-023-00694-0.","journal-title":"Nat Rev Nephrol"},{"key":"293_CR227","doi-asserted-by":"publisher","first-page":"1324996","DOI":"10.3389\/fimmu.2023.1324996","volume":"14","author":"J Guerrero-Mauvecin","year":"2023","unstructured":"Guerrero-Mauvecin J, Villar-Gomez N, Rayego-Mateos S, Ramos AM, Ruiz-Ortega M, Ortiz A, et al. Regulated necrosis role in inflammation and repair in acute kidney injury. Front Immunol. 2023;14:1324996. https:\/\/doi.org\/10.3389\/fimmu.2023.1324996.","journal-title":"Front Immunol"},{"issue":"2","key":"293_CR228","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41419-024-06525-9","volume":"15","author":"N Ma","year":"2024","unstructured":"Ma N, Lu H, Li N, Ni W, Zhang W, Liu Q, et al. CHOP-mediated Gasdermin E expression promotes pyroptosis, inflammation, and mitochondrial damage in renal ischemia-reperfusion injury. Cell Death Dis. 2024;15(2):163. https:\/\/doi.org\/10.1038\/s41419-024-06525-9.","journal-title":"Cell Death Dis"},{"key":"293_CR229","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02137-9","author":"LM Zhang","year":"2024","unstructured":"Zhang LM, Liu XM, Guo DW, Li F, Hao J, Zhao S. FBXW7-Mediated Downregulation of GPX4 Aggravates Acute Kidney Injury Following Ischemia-Reperfusion. Inflammation. 2024. https:\/\/doi.org\/10.1007\/s10753-024-02137-9.","journal-title":"Inflammation"},{"key":"293_CR230","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.2147\/JIR.S465910","volume":"17","author":"L Yang","year":"2024","unstructured":"Yang L, Xu Y, Pan J, Li R, Lan C, Zhang D. Discovery of mmu-lncRNA129814\/hsa-lncRNA582795 as a Potential Biomarker and Intervention Target for Ischemia Reperfusion Injury-Induced AKI. J Inflamm Res. 2024;17:4277\u201396. https:\/\/doi.org\/10.2147\/JIR.S465910.","journal-title":"J Inflamm Res"},{"issue":"1","key":"293_CR231","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12882-024-03648-1","volume":"25","author":"X Niu","year":"2024","unstructured":"Niu X, Wang C, Li H, Chen W. Role of OPG\/RANKL\/RANK\/TLR4 signaling pathway in sepsis-associated acute kidney injury. BMC Nephrol. 2024;25(1):205. https:\/\/doi.org\/10.1186\/s12882-024-03648-1.","journal-title":"BMC Nephrol"},{"issue":"2","key":"293_CR232","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ndt\/gfz016","volume":"35","author":"SN Heyman","year":"2020","unstructured":"Heyman SN, Gorelik Y, Zorbavel D, Rosenberger C, Abassi Z, Rosen S, et al. Near-drowning: new perspectives for human hypoxic acute kidney injury. Nephrol Dial Transplant. 2020;35(2):206\u201312. https:\/\/doi.org\/10.1093\/ndt\/gfz016.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"293_CR233","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00018-024-05289-x","volume":"81","author":"Y Wang","year":"2024","unstructured":"Wang Y, Kuang Z, Xing X, Qiu Y, Zhang J, Shao D, et al. Proximal tubular FHL2, a novel downstream target of hypoxia inducible factor 1, is a protector against ischemic acute kidney injury. Cell Mol Life Sci. 2024;81(1):244. https:\/\/doi.org\/10.1007\/s00018-024-05289-x.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"293_CR234","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12967-024-05279-4","volume":"22","author":"Y Su","year":"2024","unstructured":"Su Y, Wang P, Hu Y, Liu WJ, Zhang YJ, Chen JQ, et al. AKI-Pro score for predicting progression to severe acute kidney injury or death in patients with early acute kidney injury after cardiac surgery. J Transl Med. 2024;22(1):571. https:\/\/doi.org\/10.1186\/s12967-024-05279-4.","journal-title":"J Transl Med"},{"issue":"1","key":"293_CR235","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41420-024-01843-5","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li Z, Zhang H, Chen H, Hao J, Liu H, et al. Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury. Cell Death Discov. 2024;10(1):69. https:\/\/doi.org\/10.1038\/s41420-024-01843-5.","journal-title":"Cell Death Discov"},{"issue":"1","key":"293_CR236","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s42003-023-05226-x","volume":"6","author":"L Su","year":"2023","unstructured":"Su L, Zhang J, Wang J, Wang X, Cao E, Yang C, et al. Pannexin 1 targets mitophagy to mediate renal ischemia\/reperfusion injury. Commun Biol. 2023;6(1):889. https:\/\/doi.org\/10.1038\/s42003-023-05226-x.","journal-title":"Commun Biol"},{"issue":"1","key":"293_CR237","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/toxsci\/kfv038","volume":"145","author":"RM Whitaker","year":"2015","unstructured":"Whitaker RM, Korrapati MC, Stallons LJ, Jesinkey SR, Arthur JM, Beeson CC, et al. Urinary ATP Synthase Subunit beta Is a Novel Biomarker of Renal Mitochondrial Dysfunction in Acute Kidney Injury. Toxicol Sci. 2015;145(1):108\u201317. https:\/\/doi.org\/10.1093\/toxsci\/kfv038.","journal-title":"Toxicol Sci"},{"key":"293_CR238","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.mito.2021.10.003","volume":"61","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhang Y, Wu M, Li Z, Li X, Liu Z, et al. Importance of urinary mitochondrial DNA in diagnosis and prognosis of kidney diseases. Mitochondrion. 2021;61:174\u20138. https:\/\/doi.org\/10.1016\/j.mito.2021.10.003.","journal-title":"Mitochondrion"},{"issue":"9","key":"293_CR239","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/biom14091165","volume":"14","author":"S Gupta","year":"2024","unstructured":"Gupta S, Mandal S, Banerjee K, Almarshood H, Pushpakumar SB, Sen U. Complex Pathophysiology of Acute Kidney Injury (AKI) in Aging: Epigenetic Regulation, Matrix Remodeling, and the Healing Effects of H(2)S. Biomolecules. 2024;14(9):1165. https:\/\/doi.org\/10.3390\/biom14091165.","journal-title":"Biomolecules."},{"key":"293_CR240","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2147\/JIR.S451402","volume":"17","author":"Y Li","year":"2024","unstructured":"Li Y, Ma S, Wang Z, Shi M, Zeng R, Yao Y. Gclc as a Marker for Injured Distal Nephron in Ischemia-Reperfusion Induced Acute Kidney Injury. J Inflamm Res. 2024;17:527\u201340. https:\/\/doi.org\/10.2147\/JIR.S451402.","journal-title":"J Inflamm Res"},{"issue":"5","key":"293_CR241","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s10753-024-01993-9","volume":"47","author":"X Li","year":"2024","unstructured":"Li X, Zhou X, Ping X, Zhao X, Kang H, Zhang Y, et al. Combined Plasma Olink Proteomics and Transcriptomics Identifies CXCL1 and TNFRSF12A as Potential Predictive and Diagnostic Inflammatory Markers for Acute Kidney Injury. Inflammation. 2024;47(5):1547\u201363. https:\/\/doi.org\/10.1007\/s10753-024-01993-9.","journal-title":"Inflammation"},{"issue":"1","key":"293_CR242","doi-asserted-by":"publisher","first-page":"2408146","DOI":"10.1080\/15592294.2024.2408146","volume":"19","author":"R You","year":"2024","unstructured":"You R, Quan X, Xia P, Zhang C, Liu A, Liu H, et al. A promising application of kidney-specific cell-free DNA methylation markers in real-time monitoring sepsis-induced acute kidney injury. Epigenetics. 2024;19(1):2408146. https:\/\/doi.org\/10.1080\/15592294.2024.2408146.","journal-title":"Epigenetics"},{"key":"293_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156798","volume":"184","author":"L Yuan","year":"2024","unstructured":"Yuan L, Zhou Y, Wang R, Huang X, Tang R, Yan F. Unveiling the role of sTLR2: A novel biomarker for predicting septic-associated AKI. Cytokine. 2024;184: 156798. https:\/\/doi.org\/10.1016\/j.cyto.2024.156798.","journal-title":"Cytokine"},{"key":"293_CR244","doi-asserted-by":"publisher","unstructured":"Xu J, Chen J, Li M, Jiang Z, Fang F, Hu J, et al. Utility of plasma suPAR to identify AKI and sepsis associated AKI in critically ill children. iScience. 2024;27(11):111247. https:\/\/doi.org\/10.1016\/j.isci.2024.111247","DOI":"10.1016\/j.isci.2024.111247"},{"issue":"2","key":"293_CR245","doi-asserted-by":"publisher","first-page":"2438855","DOI":"10.1080\/0886022X.2024.2438855","volume":"46","author":"Y Fu","year":"2024","unstructured":"Fu Y, Zhang Z, He C, Jia L, Ge C, Long L, et al. Performance of urinary C-C motif chemokine ligand 14 and the renal resistive index in predicting persistent AKI. Ren Fail. 2024;46(2):2438855. https:\/\/doi.org\/10.1080\/0886022X.2024.2438855.","journal-title":"Ren Fail"},{"issue":"1","key":"293_CR246","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00280-024-04737-6","volume":"95","author":"T Uchino","year":"2024","unstructured":"Uchino T, Iwano Y, Miyazaki Y, Nakajo M, Osawa M, Nagai E, et al. Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer. Cancer Chemother Pharmacol. 2024;95(1):11. https:\/\/doi.org\/10.1007\/s00280-024-04737-6.","journal-title":"Cancer Chemother Pharmacol"},{"key":"293_CR247","doi-asserted-by":"publisher","unstructured":"Holthoff JH, Alge JL, Arthur JM, Ayub F, Bin Homam W, Janech MG, et al. Urinary Complement C3 and Vitamin D-Binding Protein Predict Adverse Outcomes in Patients with Acute Kidney Injury after Cardiac Surgery. Nephron. 2025;149(2): 66\u201376. https:\/\/doi.org\/10.1159\/000540664","DOI":"10.1159\/000540664"},{"key":"293_CR248","doi-asserted-by":"publisher","first-page":"1430776","DOI":"10.3389\/fcvm.2024.1430776","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Huang H, Zhou H. Elevated postoperative systemic immune-inflammation index associates with acute kidney injury after cardiac surgery: a large-scale cohort study. Front Cardiovasc Med. 2024;11:1430776. https:\/\/doi.org\/10.3389\/fcvm.2024.1430776.","journal-title":"Front Cardiovasc Med"},{"key":"293_CR249","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.2147\/JIR.S370085","volume":"15","author":"K Ma","year":"2022","unstructured":"Ma K, Qiu H, Zhu Y, Lu Y, Li W. Preprocedural SII Combined with High-Sensitivity C-Reactive Protein Predicts the Risk of Contrast-Induced Acute Kidney Injury in STEMI Patients Undergoing Percutaneous Coronary Intervention. J Inflamm Res. 2022;15:3677\u201387. https:\/\/doi.org\/10.2147\/JIR.S370085.","journal-title":"J Inflamm Res"},{"issue":"4","key":"293_CR250","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10638","volume":"9","author":"L Ren","year":"2024","unstructured":"Ren L, Zhao Y, Wang T, Tong Y, Zhao P, Nie F, et al. Ultrasound molecular imaging for early detection of acute renal ischemia-reperfusion injury. Bioeng Transl Med. 2024;9(4): e10638. https:\/\/doi.org\/10.1002\/btm2.10638.","journal-title":"Bioeng Transl Med"},{"issue":"19","key":"293_CR251","doi-asserted-by":"publisher","first-page":"7534","DOI":"10.7150\/thno.101229","volume":"14","author":"W He","year":"2024","unstructured":"He W, Ding C, Lin T, Wang B, Wang W, Deng Z, et al. An enzyme-mimicking reactive oxygen species scavenger targeting oxidative stress-inflammation cycle ameliorates IR-AKI by inhibiting pyruvate dehydrogenase kinase 4. Theranostics. 2024;14(19):7534\u201353. https:\/\/doi.org\/10.7150\/thno.101229.","journal-title":"Theranostics"},{"issue":"8","key":"293_CR252","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/ckj\/sfaa221","volume":"14","author":"C Buchanan","year":"2021","unstructured":"Buchanan C, Mahmoud H, Cox E, Noble R, Prestwich B, Kasmi I, et al. Multiparametric MRI assessment of renal structure and function in acute kidney injury and renal recovery. Clin Kidney J. 2021;14(8):1969\u201376. https:\/\/doi.org\/10.1093\/ckj\/sfaa221.","journal-title":"Clin Kidney J"},{"issue":"1","key":"293_CR253","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jmri.28784","volume":"59","author":"B Wang","year":"2024","unstructured":"Wang B, Wang Y, Wang J, Jin C, Zhou R, Guo J, et al. Multiparametric Magnetic Resonance Investigations on Acute and Long-Term Kidney Injury. J Magn Reson Imaging. 2024;59(1):43\u201357. https:\/\/doi.org\/10.1002\/jmri.28784.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"293_CR254","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jmri.29094","volume":"60","author":"Q Tao","year":"2024","unstructured":"Tao Q, Zhang Q, An Z, Chen Z, Feng Y. Multi-Parametric MRI for Evaluating Variations in Renal Structure, Function, and Endogenous Metabolites in an Animal Model With Acute Kidney Injury Induced by Ischemia Reperfusion. J Magn Reson Imaging. 2024;60(1):245\u201355. https:\/\/doi.org\/10.1002\/jmri.29094.","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"293_CR255","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1021\/acs.molpharmaceut.3c00531","volume":"20","author":"S Nijiati","year":"2023","unstructured":"Nijiati S, Zeng F, Zuo C, Zhang Q, Du C, Shi C, et al. Fe(II)-Targeted PET\/(19)F MRI Dual-Modal Molecular Imaging Probe for Early Evaluation of Anticancer Drug-Induced Acute Kidney Injury. Mol Pharm. 2023;20(10):5185\u201394. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00531.","journal-title":"Mol Pharm"},{"issue":"18","key":"293_CR256","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311397","volume":"36","author":"W Zhang","year":"2024","unstructured":"Zhang W, Chan C, Zhang K, Qin H, Yu BY, Xue Z, et al. Discovering a New Drug Against Acute Kidney Injury by Using a Tailored Photoacoustic Imaging Probe. Adv Mater. 2024;36(18): e2311397. https:\/\/doi.org\/10.1002\/adma.202311397.","journal-title":"Adv Mater"},{"key":"293_CR257","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105294","volume":"107","author":"ZL Li","year":"2024","unstructured":"Li ZL, Li XY, Zhou Y, Wang B, Lv LL, Liu BC. Renal tubular epithelial cells response to injury in acute kidney injury. EBioMedicine. 2024;107: 105294. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105294.","journal-title":"EBioMedicine"},{"issue":"1","key":"293_CR258","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12882-021-02268-3","volume":"22","author":"S Chen","year":"2021","unstructured":"Chen S, Liu YH, Dai DP, Zhu ZB, Dai Y, Wu ZM, et al. Using circulating O-sulfotyrosine in the differential diagnosis of acute kidney injury and chronic kidney disease. BMC Nephrol. 2021;22(1):66. https:\/\/doi.org\/10.1186\/s12882-021-02268-3.","journal-title":"BMC Nephrol"},{"issue":"1","key":"293_CR259","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40360-024-00809-8","volume":"25","author":"ER Alaasam","year":"2024","unstructured":"Alaasam ER, Janabi AM, Al-Buthabhak KM, Almudhafar RH, Hadi NR, Alexiou A, et al. Nephroprotective role of resveratrol in renal ischemia-reperfusion injury: a preclinical study in Sprague-Dawley rats. BMC Pharmacol Toxicol. 2024;25(1):82. https:\/\/doi.org\/10.1186\/s40360-024-00809-8.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"293_CR260","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s13287-024-04025-3","volume":"15","author":"X Geng","year":"2024","unstructured":"Geng X, Fu Z, Geng G, Chi K, Liu C, Hong H, et al. Astilbin improves the therapeutic effects of mesenchymal stem cells in AKI-CKD mice by regulating macrophage polarization through PTGS2-mediated pathway. Stem Cell Res Ther. 2024;15(1):427. https:\/\/doi.org\/10.1186\/s13287-024-04025-3.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"293_CR261","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/011574888X296559240326063705","volume":"20","author":"Y Kuang","year":"2024","unstructured":"Kuang Y, Fan C, Long X, Zheng J, Zeng Y, Wei Y, et al. The Renoprotective and Anti-Inflammatory Effects of Human Urine-Derived Stem Cells on Acute Kidney Injury Animals. Curr Stem Cell Res Ther. 2024;20(2):199\u2013210. https:\/\/doi.org\/10.2174\/011574888X296559240326063705.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"1","key":"293_CR262","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/15548627.2024.2393926","volume":"21","author":"XR Huang","year":"2025","unstructured":"Huang XR, Ye L, An N, Wu CY, Wu HL, Li HY, et al. Macrophage autophagy protects against acute kidney injury by inhibiting renal inflammation through the degradation of TARM1. Autophagy. 2025;21(1):120\u201340. https:\/\/doi.org\/10.1080\/15548627.2024.2393926.","journal-title":"Autophagy"},{"key":"293_CR263","doi-asserted-by":"publisher","DOI":"10.1007\/s10877-024-01209-3","author":"A Messina","year":"2024","unstructured":"Messina A, Calatroni M, Castellani G, De Rosa S, Ostermann M, Cecconi M. Understanding fluid dynamics and renal perfusion in acute kidney injury management. J Clin Monit Comput. 2024. https:\/\/doi.org\/10.1007\/s10877-024-01209-3.","journal-title":"J Clin Monit Comput"},{"issue":"6","key":"293_CR264","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00134-021-06401-6","volume":"47","author":"ST Vaara","year":"2021","unstructured":"Vaara ST, Ostermann M, Bitker L, Schneider A, Poli E, Hoste E, et al. Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial. Intensive Care Med. 2021;47(6):665\u201373. https:\/\/doi.org\/10.1007\/s00134-021-06401-6.","journal-title":"Intensive Care Med"},{"issue":"14","key":"293_CR265","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1042\/CS20210100","volume":"135","author":"M Wu","year":"2021","unstructured":"Wu M, Chen W, Miao M, Jin Q, Zhang S, Bai M, et al. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability. Clin Sci (Lond). 2021;135(14):1707\u201326. https:\/\/doi.org\/10.1042\/CS20210100.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"293_CR266","doi-asserted-by":"publisher","first-page":"F608","DOI":"10.1152\/ajprenal.00554.2020","volume":"320","author":"W Gong","year":"2021","unstructured":"Gong W, Lu L, Zhou Y, Liu J, Ma H, Fu L, et al. The novel STING antagonist H151 ameliorates cisplatin-induced acute kidney injury and mitochondrial dysfunction. Am J Physiol Renal Physiol. 2021;320(4):F608\u201316. https:\/\/doi.org\/10.1152\/ajprenal.00554.2020.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"293_CR267","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2403769","volume":"391","author":"G Landoni","year":"2024","unstructured":"Landoni G, Monaco F, Ti LK, Baiardo Redaelli M, Bradic N, Comis M, et al. A Randomized Trial of Intravenous Amino Acids for Kidney Protection. N Engl J Med. 2024;391(8):687\u201398. https:\/\/doi.org\/10.1056\/NEJMoa2403769.","journal-title":"N Engl J Med"},{"issue":"9","key":"293_CR268","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41591-018-0138-z","volume":"24","author":"A Poyan Mehr","year":"2018","unstructured":"Poyan Mehr A, Tran MT, Ralto KM, Leaf DE, Washco V, Messmer J, et al. De novo NAD(+) biosynthetic impairment in acute kidney injury in humans. Nat Med. 2018;24(9):1351\u20139. https:\/\/doi.org\/10.1038\/s41591-018-0138-z.","journal-title":"Nat Med"},{"issue":"1","key":"293_CR269","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00134-023-07271-w","volume":"50","author":"P Pickkers","year":"2024","unstructured":"Pickkers P, Angus DC, Bass K, Bellomo R, van den Berg E, Bernholz J, et al. Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL). Intensive Care Med. 2024;50(1):68\u201378. https:\/\/doi.org\/10.1007\/s00134-023-07271-w.","journal-title":"Intensive Care Med"},{"key":"293_CR270","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.124.002282","author":"C Chen","year":"2024","unstructured":"Chen C, Wang W, Poklis JL, Li PL, Lichtman AH, Gewirtz DA, et al. Mitigation of cisplatin-induced acute kidney injury through oral administration of FAAH Inhibitor PF-04457845. J Pharmacol Exp Ther. 2024. https:\/\/doi.org\/10.1124\/jpet.124.002282.","journal-title":"J Pharmacol Exp Ther"},{"key":"293_CR271","doi-asserted-by":"publisher","unstructured":"Coca A, Bustamante-Munguira E, Fidalgo V, Fernandez M, Abad C, Franco M, et al. EValuating the Effect of periopeRaTIve empaGliflOzin on cardiac surgery associated acute kidney injury: rationale and design of the VERTIGO study. Clin Kidney J. 2024;17(8):sfae229. https:\/\/doi.org\/10.1093\/ckj\/sfae229","DOI":"10.1093\/ckj\/sfae229"},{"issue":"1","key":"293_CR272","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12906-023-04323-y","volume":"24","author":"A Huo","year":"2024","unstructured":"Huo A, Wang F. Berberine alleviates ischemia reperfusion injury induced AKI by regulation of intestinal microbiota and reducing intestinal inflammation. BMC Complement Med Ther. 2024;24(1):66. https:\/\/doi.org\/10.1186\/s12906-023-04323-y.","journal-title":"BMC Complement Med Ther"},{"key":"293_CR273","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113705","volume":"144","author":"B Jiang","year":"2025","unstructured":"Jiang B, Liu J, Qu Z, Wang Y, Wang Y, Li Z, et al. Mechanism of dihydroartemisinin in the treatment of ischaemia\/reperfusion-induced acute kidney injury via network pharmacology, molecular dynamics simulation and experiments. Int Immunopharmacol. 2025;144: 113705. https:\/\/doi.org\/10.1016\/j.intimp.2024.113705.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"293_CR274","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41419-024-07299-w","volume":"15","author":"K Liu","year":"2024","unstructured":"Liu K, Hao X, Gao Y, Cao Z, Hou M, Qin L, et al. CUL4B protects kidneys from acute injury by restraining p53\/PAI-1 signaling. Cell Death Dis. 2024;15(12):915. https:\/\/doi.org\/10.1038\/s41419-024-07299-w.","journal-title":"Cell Death Dis"},{"issue":"1","key":"293_CR275","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s11658-024-00553-1","volume":"29","author":"Z Song","year":"2024","unstructured":"Song Z, Xia Y, Shi L, Zha H, Huang J, Xiang X, et al. Inhibition of Drp1- Fis1 interaction alleviates aberrant mitochondrial fragmentation and acute kidney injury. Cell Mol Biol Lett. 2024;29(1):31. https:\/\/doi.org\/10.1186\/s11658-024-00553-1.","journal-title":"Cell Mol Biol Lett"},{"issue":"8","key":"293_CR276","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165809","volume":"1866","author":"H Jabbari","year":"2020","unstructured":"Jabbari H, Roushandeh AM, Rostami MK, Razavi-Toosi MT, Shokrgozar MA, Jahanian-Najafabadi A, et al. Mitochondrial transplantation ameliorates ischemia\/reperfusion-induced kidney injury in rat. Biochim Biophys Acta Mol Basis Dis. 2020;1866(8): 165809. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165809.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"293_CR277","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1097\/SLA.0000000000006005","volume":"278","author":"A Rossi","year":"2023","unstructured":"Rossi A, Asthana A, Riganti C, Sedrakyan S, Byers LN, Robertson J, et al. Mitochondria Transplantation Mitigates Damage in an In Vitro Model of Renal Tubular Injury and in an Ex Vivo Model of DCD Renal Transplantation. Ann Surg. 2023;278(6):e1313\u201326. https:\/\/doi.org\/10.1097\/SLA.0000000000006005.","journal-title":"Ann Surg"},{"issue":"45","key":"293_CR278","doi-asserted-by":"publisher","first-page":"62693","DOI":"10.1021\/acsami.4c14169","volume":"16","author":"Z Shen","year":"2024","unstructured":"Shen Z, Wang X, Lu L, Wang R, Hu D, Fan Z, et al. Bilirubin-Modified Chondroitin Sulfate-Mediated Multifunctional Liposomes Ameliorate Acute Kidney Injury by Inducing Mitophagy and Regulating Macrophage Polarization. ACS Appl Mater Interfaces. 2024;16(45):62693\u2013709. https:\/\/doi.org\/10.1021\/acsami.4c14169.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"22","key":"293_CR279","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1042\/CS20241713","volume":"138","author":"TT Chang","year":"2024","unstructured":"Chang TT, Li SY, Tsai MT, Chiang CH, Chen C, Chen JW. CXCL5 inhibition ameliorates acute kidney injury and prevents the progression from acute kidney injury to chronic kidney disease. Clin Sci (Lond). 2024;138(22):1451\u201366. https:\/\/doi.org\/10.1042\/CS20241713.","journal-title":"Clin Sci (Lond)"},{"key":"293_CR280","doi-asserted-by":"publisher","DOI":"10.1093\/jpp\/rgae134","author":"LR Zhu","year":"2024","unstructured":"Zhu LR, Cui W, Liu HP. Molecular mechanisms of endoplasmic reticulum stress-mediated acute kidney injury in juvenile rats and the protective role of mesencephalic astrocyte-derived neurotrophic factor. J Pharm Pharmacol. 2024. https:\/\/doi.org\/10.1093\/jpp\/rgae134.","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"293_CR281","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2024.152832","volume":"229","author":"Y Wang","year":"2024","unstructured":"Wang Y, Cui C, Zhao W, Tian X, Liu P, Wei L, et al. WIP1-mediated regulation of p38 MAPK signaling attenuates pyroptosis in sepsis-associated acute kidney injury. Immunobiology. 2024;229(5): 152832. https:\/\/doi.org\/10.1016\/j.imbio.2024.152832.","journal-title":"Immunobiology"},{"issue":"6","key":"293_CR282","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302299RR","volume":"38","author":"P Wang","year":"2024","unstructured":"Wang P, Li C, Peng T, Ruan L, Wu A, Zhu J, et al. Tolerogenic CD11c(+)dendritic cells regulate CD4(+)Tregs in replacing delayed ischemic preconditioning to alleviate ischemia-reperfusion acute kidney injury. FASEB J. 2024;38(6): e23575. https:\/\/doi.org\/10.1096\/fj.202302299RR.","journal-title":"FASEB J"},{"issue":"18","key":"293_CR283","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303901","volume":"11","author":"W Jiang","year":"2024","unstructured":"Jiang W, Hou X, Qi Y, Wang Z, Liu Y, Gao XJ, et al. pH-Activatable Pre-Nanozyme Mediated H(2)S Delivery for Endo-Exogenous Regulation of Oxidative Stress in Acute Kidney Injury. Adv Sci (Weinh). 2024;11(18): e2303901. https:\/\/doi.org\/10.1002\/advs.202303901.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"293_CR284","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302729","volume":"13","author":"Q Long","year":"2024","unstructured":"Long Q, Liao F, Yi H, Wang M, Zhuang J, Zheng Y, et al. Biodegradable Osmium Nanoantidotes for Photothermal-\/Chemo- Combined Treatment and to Prevent Chemotherapy-Induced Acute Kidney Injury. Adv Healthc Mater. 2024;13(7): e2302729. https:\/\/doi.org\/10.1002\/adhm.202302729.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"293_CR285","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1021\/acsami.4c14815","volume":"17","author":"J Sun","year":"2025","unstructured":"Sun J, Shen H, Dong J, Zhang J, Yue T, Zhang R. Melanin-Deferoxamine Nanoparticles Targeting Ferroptosis Mitigate Acute Kidney Injury via RONS Scavenging and Iron Ion Chelation. ACS Appl Mater Interfaces. 2025;17(1):282\u201396. https:\/\/doi.org\/10.1021\/acsami.4c14815.","journal-title":"ACS Appl Mater Interfaces"},{"key":"293_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122926","volume":"315","author":"H Li","year":"2025","unstructured":"Li H, Ouyang Y, Lv H, Liang H, Luo S, Zhang Y, et al. Nanoparticle-mediated Klotho gene therapy prevents acute kidney injury to chronic kidney disease transition through regulating PPARalpha signaling in renal tubular epithelial cells. Biomaterials. 2025;315: 122926. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122926.","journal-title":"Biomaterials"},{"issue":"11","key":"293_CR287","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00134-023-07211-8","volume":"49","author":"R Wald","year":"2023","unstructured":"Wald R, Gaudry S, da Costa BR, Adhikari NKJ, Bellomo R, Du B, et al. Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial. Intensive Care Med. 2023;49(11):1305\u201316. https:\/\/doi.org\/10.1007\/s00134-023-07211-8.","journal-title":"Intensive Care Med"},{"issue":"1","key":"293_CR288","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13054-022-03955-9","volume":"26","author":"S Gaudry","year":"2022","unstructured":"Gaudry S, Grolleau F, Barbar S, Martin-Lefevre L, Pons B, Boulet E, et al. Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies. Crit Care. 2022;26(1):93. https:\/\/doi.org\/10.1186\/s13054-022-03955-9.","journal-title":"Crit Care"},{"key":"293_CR289","doi-asserted-by":"publisher","unstructured":"Investigators S-A, Canadian Critical Care Trials G, Australian, New Zealand Intensive Care Society Clinical Trials G, United Kingdom Critical Care Research G, Canadian Nephrology Trials N, et al. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med. 2020;383(3):240\u201351. https:\/\/doi.org\/10.1056\/NEJMoa2000741","DOI":"10.1056\/NEJMoa2000741"},{"issue":"1","key":"293_CR290","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00467-024-06311-x","volume":"40","author":"R Raina","year":"2025","unstructured":"Raina R, Nair N, Pelletier J, Nied M, Whitham T, Doshi K, et al. Concurrent use of continuous kidney replacement therapy during extracorporeal membrane oxygenation: what pediatric nephrologists need to know-PCRRT-ICONIC practice points. Pediatr Nephrol. 2025;40(1):267\u201384. https:\/\/doi.org\/10.1007\/s00467-024-06311-x.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"293_CR291","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12882-024-03897-0","volume":"25","author":"F Zheng","year":"2024","unstructured":"Zheng F, Wang YL, Zhou WY, Zhang J, Lu M, Pan NF, et al. Continuous renal replacement therapy with adsorbing filter oXiris in the treatment of sepsis associated acute kidney injury: a single-center retrospective observational study. BMC Nephrol. 2024;25(1):456. https:\/\/doi.org\/10.1186\/s12882-024-03897-0.","journal-title":"BMC Nephrol"},{"key":"293_CR292","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-024-02142-z","author":"M Napoli","year":"2025","unstructured":"Napoli M, Gianfreda D, Matino S, Ria P, Zito A, Fonto G, et al. The role of a \u201cvolume sparing\u201d strategy in kidney replacement therapy of AKI: a retrospective single-center study. J Nephrol. 2025. https:\/\/doi.org\/10.1007\/s40620-024-02142-z.","journal-title":"J Nephrol"},{"key":"293_CR293","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2024.104648","volume":"154","author":"Y Tan","year":"2024","unstructured":"Tan Y, Dede M, Mohanty V, Dou J, Hill H, Bernstam E, et al. Forecasting acute kidney injury and resource utilization in ICU patients using longitudinal, multimodal models. J Biomed Inform. 2024;154: 104648. https:\/\/doi.org\/10.1016\/j.jbi.2024.104648.","journal-title":"J Biomed Inform"},{"issue":"4","key":"293_CR294","doi-asserted-by":"publisher","first-page":"F362","DOI":"10.1152\/ajprenal.00037.2023","volume":"324","author":"BD Humphreys","year":"2023","unstructured":"Humphreys BD. Caught in the crossfire: cancer, cisplatin therapy, and kidney injury. Am J Physiol Renal Physiol. 2023;324(4):F362\u20133. https:\/\/doi.org\/10.1152\/ajprenal.00037.2023.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"293_CR295","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/ijms25031755","volume":"25","author":"TH Yeh","year":"2024","unstructured":"Yeh TH, Tu KC, Wang HY, Chen JY. From Acute to Chronic: Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease. Int J Mol Sci. 2024;25(3):1755. https:\/\/doi.org\/10.3390\/ijms25031755.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"293_CR296","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12916-022-02428-8","volume":"20","author":"H Wang","year":"2022","unstructured":"Wang H, Lambourg E, Guthrie B, Morales DR, Donnan PT, Bell S. Patient outcomes following AKI and AKD: a population-based cohort study. BMC Med. 2022;20(1):229. https:\/\/doi.org\/10.1186\/s12916-022-02428-8.","journal-title":"BMC Med"},{"issue":"2","key":"293_CR297","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00134-023-07314-2","volume":"50","author":"M Meersch","year":"2024","unstructured":"Meersch M, Weiss R, Strauss C, Albert F, Booke H, Forni L, et al. Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial. Intensive Care Med. 2024;50(2):247\u201357. https:\/\/doi.org\/10.1007\/s00134-023-07314-2.","journal-title":"Intensive Care Med"},{"issue":"4","key":"293_CR298","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/ckj\/sfad011","volume":"16","author":"T Vanhoutte","year":"2023","unstructured":"Vanhoutte T, Sprangers B. Pseudo-AKI associated with targeted anti-cancer agents-the truth is in the eye of the filtration marker. Clin Kidney J. 2023;16(4):603\u201310. https:\/\/doi.org\/10.1093\/ckj\/sfad011.","journal-title":"Clin Kidney J"},{"issue":"5","key":"293_CR299","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.28478","volume":"120","author":"EM Brosnan","year":"2014","unstructured":"Brosnan EM, Weickhardt AJ, Lu X, Maxon DA, Baron AE, Chonchol M, et al. Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib. Cancer. 2014;120(5):664\u201374. https:\/\/doi.org\/10.1002\/cncr.28478.","journal-title":"Cancer"},{"issue":"9","key":"293_CR300","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.xphs.2017.03.013","volume":"106","author":"H Arakawa","year":"2017","unstructured":"Arakawa H, Omote S, Tamai I. Inhibitory Effect of Crizotinib on Creatinine Uptake by Renal Secretory Transporter OCT2. J Pharm Sci. 2017;106(9):2899\u2013903. https:\/\/doi.org\/10.1016\/j.xphs.2017.03.013.","journal-title":"J Pharm Sci"},{"key":"293_CR301","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2147\/DDDT.S249098","volume":"14","author":"D Zhao","year":"2020","unstructured":"Zhao D, Chen J, Chu M, Long X, Wang J. Pharmacokinetic-Based Drug-Drug Interactions with Anaplastic Lymphoma Kinase Inhibitors: A Review. Drug Des Devel Ther. 2020;14:1663\u201381. https:\/\/doi.org\/10.2147\/DDDT.S249098.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"293_CR302","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/ckj\/sfac180","volume":"16","author":"V Wijtvliet","year":"2023","unstructured":"Wijtvliet V, Roosens L, De Bondt C, Janssens A, Abramowicz D. Pseudo-acute kidney injury secondary to tepotinib. Clin Kidney J. 2023;16(4):760\u20131. https:\/\/doi.org\/10.1093\/ckj\/sfac180.","journal-title":"Clin Kidney J"},{"issue":"1","key":"293_CR303","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ajkd.2021.04.009","volume":"79","author":"A Mohan","year":"2022","unstructured":"Mohan A, Herrmann SM. Capmatinib-Induced Pseudo-Acute Kidney Injury: A Case Report. Am J Kidney Dis. 2022;79(1):120\u20134. https:\/\/doi.org\/10.1053\/j.ajkd.2021.04.009.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"293_CR304","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.clml.2015.12.001","volume":"16","author":"E Vidal-Petiot","year":"2016","unstructured":"Vidal-Petiot E, Rea D, Serrano F, Stehle T, Gardin C, Rousselot P, et al. Imatinib Increases Serum Creatinine by Inhibiting Its Tubular Secretion in a Reversible Fashion in Chronic Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2016;16(3):169\u201374. https:\/\/doi.org\/10.1016\/j.clml.2015.12.001.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"293_CR305","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/cpt.1296","volume":"105","author":"JC Chappell","year":"2019","unstructured":"Chappell JC, Turner PK, Pak YA, Bacon J, Chiang AY, Royalty J, et al. Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate. Clin Pharmacol Ther. 2019;105(5):1187\u201395. https:\/\/doi.org\/10.1002\/cpt.1296.","journal-title":"Clin Pharmacol Ther"},{"key":"293_CR306","doi-asserted-by":"publisher","first-page":"205435812211062","DOI":"10.1177\/20543581221106246","volume":"9","author":"T Mach","year":"2022","unstructured":"Mach T, Qi A, Bouganim N, Trinh E. Targeted Cancer Therapies Causing Elevations in Serum Creatinine Through Tubular Secretion Inhibition: A Case Report and Review of the Literature. Can J Kidney Health Dis. 2022;9:20543581221106250. https:\/\/doi.org\/10.1177\/20543581221106246.","journal-title":"Can J Kidney Health Dis"},{"issue":"4","key":"293_CR307","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jcph.1750","volume":"61","author":"AR Topletz-Erickson","year":"2021","unstructured":"Topletz-Erickson AR, Lee AJ, Mayor JG, Rustia EL, Abdulrasool LI, Wise AL, et al. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects. J Clin Pharmacol. 2021;61(4):461\u201371. https:\/\/doi.org\/10.1002\/jcph.1750.","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"293_CR308","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/00498254.2016.1241449","volume":"47","author":"A McCormick","year":"2017","unstructured":"McCormick A, Swaisland H. In vitro assessment of the roles of drug transporters in the disposition and drug-drug interaction potential of olaparib. Xenobiotica. 2017;47(10):903\u201315. https:\/\/doi.org\/10.1080\/00498254.2016.1241449.","journal-title":"Xenobiotica"},{"issue":"13","key":"293_CR309","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.3390\/cancers13133373","volume":"13","author":"M Matuszczak","year":"2021","unstructured":"Matuszczak M, Schalken JA, Salagierski M. Prostate Cancer Liquid Biopsy Biomarkers\u2019 Clinical Utility in Diagnosis and Prognosis. Cancers (Basel). 2021;13(13):3373. https:\/\/doi.org\/10.3390\/cancers13133373.","journal-title":"Cancers (Basel)."},{"issue":"15","key":"293_CR310","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.3390\/ijms23158597","volume":"23","author":"M Matuszczak","year":"2022","unstructured":"Matuszczak M, Kiljanczyk A, Salagierski M. A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers. Int J Mol Sci. 2022;23(15):8597. https:\/\/doi.org\/10.3390\/ijms23158597.","journal-title":"Int J Mol Sci."},{"key":"293_CR311","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119907","volume":"564","author":"K Shi","year":"2025","unstructured":"Shi K, Jiang W, Song L, Li X, Zhang C, Li L, et al. Persistent acute kidney injury biomarkers: A systematic review and meta-analysis. Clin Chim Acta. 2025;564: 119907. https:\/\/doi.org\/10.1016\/j.cca.2024.119907.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"293_CR312","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12882-024-03793-7","volume":"25","author":"TT Tran","year":"2024","unstructured":"Tran TT, Yun G, Kim S. Artificial intelligence and predictive models for early detection of acute kidney injury: transforming clinical practice. BMC Nephrol. 2024;25(1):353. https:\/\/doi.org\/10.1186\/s12882-024-03793-7.","journal-title":"BMC Nephrol"},{"issue":"1","key":"293_CR313","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41467-024-55629-5","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Xu D, Gao J, Wang R, Yan K, Liang H, et al. Development and validation of a real-time prediction model for acute kidney injury in hospitalized patients. Nat Commun. 2025;16(1):68. https:\/\/doi.org\/10.1038\/s41467-024-55629-5.","journal-title":"Nat Commun"},{"issue":"1","key":"293_CR314","doi-asserted-by":"publisher","DOI":"10.1002\/mef2.77","volume":"3","author":"Q Chen","year":"2024","unstructured":"Chen Q, Fu B, Yang J, Jin Z, Zhang L, Fan R, et al. PO-AKID-teller: an interpretable machine learning tool for predicting acute kidney injury requiring dialysis after acute type A aortic dissection surgery. Medcomm-FUTURE MEDICINE. 2024;3(1): e77. https:\/\/doi.org\/10.1002\/mef2.77.","journal-title":"Medcomm-FUTURE MEDICINE"},{"issue":"3","key":"293_CR315","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ekir.2021.11.033","volume":"7","author":"S Gupta","year":"2022","unstructured":"Gupta S, Caza T, Herrmann SM, Sakhiya VC, Jhaveri KD. Clinicopathologic Features of Acute Kidney Injury Associated With CDK4\/6 Inhibitors. Kidney Int Rep. 2022;7(3):618\u201323. https:\/\/doi.org\/10.1016\/j.ekir.2021.11.033.","journal-title":"Kidney Int Rep"},{"issue":"10","key":"293_CR316","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/biomedicines10102583","volume":"10","author":"M Matuszczak","year":"2022","unstructured":"Matuszczak M, Kiljanczyk A, Salagierski M. The Role of Focal Therapy and Active Surveillance for Small Renal Mass Therapy. Biomedicines. 2022;10(10):2583. https:\/\/doi.org\/10.3390\/biomedicines10102583.","journal-title":"Biomedicines."},{"issue":"6","key":"293_CR317","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/cancers15061804","volume":"15","author":"M Matuszczak","year":"2023","unstructured":"Matuszczak M, Kiljanczyk A, Salagierski M. Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review. Cancers (Basel). 2023;15(6):1804. https:\/\/doi.org\/10.3390\/cancers15061804.","journal-title":"Cancers (Basel)."},{"key":"293_CR318","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jconrel.2024.10.063","volume":"376","author":"JH Wang","year":"2024","unstructured":"Wang JH, Mao HB, Hu JB, Cheng S, Su H. Engineering of phosphatidylserine-targeting ROS-responsive polymeric prodrug for the repair of ischemia-reperfusion-induced acute kidney injury. J Control Release. 2024;376:1100\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.063.","journal-title":"J Control Release"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00293-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T06:21:35Z","timestamp":1757053295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00293-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":318,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00293-4","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as no patients\/participants were involved in this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors state that there are no potential competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}